
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>
GP&#8208;2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP&#8208;Kinase and impairs the NF&#8208;kB pathway in pancreatic cancer cells - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F392050000287DBAA90C95.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="jcmmopen" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10339077/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339077/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Cellular and Molecular Medicine" /><meta name="citation_title" content="&#10;GP&#x02010;2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP&#x02010;Kinase and impairs the NF&#x02010;kB pathway in pancreatic cancer cells" /><meta name="citation_author" content="Britta Majchrzak&#x02010;Stiller" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Marie Buchholz" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Ilka Peters" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Daniel Waschestjuk" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Johanna Strotmann" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Philipp H&#x000f6;hn" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Stephan Hahn" /><meta name="citation_author_institution" content="Department of Molecular Gastrointestinal Oncology, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Chris Braumann" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author_institution" content="Department of General, Visceral and Vascular Surgery, Evangelische Kliniken Gelsenkirchen, Akademisches Lehrkrankenhaus der Universit&#x000e4;t Duisburg&#x02010;Essen, Gelsenkirchen Germany" /><meta name="citation_author" content="Waldemar Uhl" /><meta name="citation_author_institution" content="Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Bochum Germany" /><meta name="citation_author" content="Thomas M&#x000fc;ller" /><meta name="citation_author_institution" content="Geistlich Pharma AG, Lucerne Switzerland" /><meta name="citation_author" content="Hanns M&#x000f6;hler" /><meta name="citation_author_institution" content="Institute of Pharmacology, University of Zurich and Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich Switzerland" /><meta name="citation_publication_date" content="2023/07" /><meta name="citation_issue" content="14" /><meta name="citation_volume" content="27" /><meta name="citation_firstpage" content="2082" /><meta name="citation_doi" content="10.1111/jcmm.17825" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10339077/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10339077/" /><meta name="citation_pmid" content="37390227" /><meta name="DC.Title" content="&#10;GP&#x02010;2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP&#x02010;Kinase and impairs the NF&#x02010;kB pathway in pancreatic cancer cells" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Wiley" /><meta name="DC.Contributor" content="Britta Majchrzak&#x02010;Stiller" /><meta name="DC.Contributor" content="Marie Buchholz" /><meta name="DC.Contributor" content="Ilka Peters" /><meta name="DC.Contributor" content="Daniel Waschestjuk" /><meta name="DC.Contributor" content="Johanna Strotmann" /><meta name="DC.Contributor" content="Philipp H&#x000f6;hn" /><meta name="DC.Contributor" content="Stephan Hahn" /><meta name="DC.Contributor" content="Chris Braumann" /><meta name="DC.Contributor" content="Waldemar Uhl" /><meta name="DC.Contributor" content="Thomas M&#x000fc;ller" /><meta name="DC.Contributor" content="Hanns M&#x000f6;hler" /><meta name="DC.Date" content="2023 Jul" /><meta name="DC.Identifier" content="10.1111/jcmm.17825" /><meta name="DC.Language" content="en" /><meta property="og:title" content="&#10;GP&#x02010;2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP&#x02010;Kinase and impairs the NF&#x02010;kB pathway in pancreatic cancer cells" /><meta property="og:type" content="article" /><meta property="og:description" content="GP&#x02010;2250, a novel anticancer agent, severely limits the energy metabolism, as demonstrated by the inhibition of hexokinase 2 and glyceraldehyde&#x02010;3&#x02010;phosphate dehydrogenase and a decrease of ATP. Rescue experiments with supplementary ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339077/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10339077/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2233/">J Cell Mol Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/440620/">v.27(14); 2023 Jul</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10339077
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10339077/pdf/JCMM-27-2082.pdf" class="int-view">PDF (3.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10339077/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10339077/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10339077" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10339077%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="VlxTsZpVC2YgOhuDmlygi1RnRky504Q7naVmsi8uOM9yzgrAtOyR5wdQrdd2cZWT">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10339077%2F&amp;text=%0AGP%020102250%2C%20a%20novel%20anticancer%20agent%2C%20inhibits%20the%20energy%20metabolism%2C%20activates%20AMP%02010Kinase%20and%20impairs%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10339077%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339077/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10339077/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37390227/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10339077/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37390227/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10339077/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10339077/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2233/">J Cell Mol Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/440620/">v.27(14); 2023 Jul</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10339077
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-jcmmopen.gif" alt="Logo of jcmmopen" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291582-4934" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">J Cell Mol Med.</span> 2023 Jul; 27(14): 2082–2092. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Jun 30. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1111%2Fjcmm.17825" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1111/jcmm.17825</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10339077</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37390227">37390227</a></div></div></div><h1 class="content-title">
<span style="fixed-case">GP</span>&#x02010;2250, a novel anticancer agent, inhibits the energy metabolism, activates <span style="fixed-case">AMP&#x02010;Kinase</span> and impairs the <span style="fixed-case">NF&#x02010;kB</span> pathway in pancreatic cancer cells</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Majchrzak&#x02010;Stiller%20B%5BAuthor%5D" id="jcmm17825-cr-0001" class="affpopup" co-rid="_co_idm140446596167120" co-class="co-affbox">Britta Majchrzak&#x02010;Stiller</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
1
,</sup><sup>
[Link]
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Buchholz%20M%5BAuthor%5D" id="jcmm17825-cr-0002" class="affpopup" co-rid="_co_idm140446572200176" co-class="co-affbox">Marie Buchholz</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peters%20I%5BAuthor%5D" id="jcmm17825-cr-0003" class="affpopup" co-rid="_co_idm140446589759472" co-class="co-affbox">Ilka Peters</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Waschestjuk%20D%5BAuthor%5D" id="jcmm17825-cr-0004" class="affpopup" co-rid="_co_idm140446593987264" co-class="co-affbox">Daniel Waschestjuk</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Strotmann%20J%5BAuthor%5D" id="jcmm17825-cr-0005" class="affpopup" co-rid="_co_idm140446597409376" co-class="co-affbox">Johanna Strotmann</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=H&#x000f6;hn%20P%5BAuthor%5D" id="jcmm17825-cr-0006" class="affpopup" co-rid="_co_idm140446593421568" co-class="co-affbox">Philipp H&#x000f6;hn</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hahn%20S%5BAuthor%5D" id="jcmm17825-cr-0007" class="affpopup" co-rid="_co_idm140446593419072" co-class="co-affbox">Stephan Hahn</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Braumann%20C%5BAuthor%5D" id="jcmm17825-cr-0008" class="affpopup" co-rid="_co_idm140446637557104" co-class="co-affbox">Chris Braumann</a>,<sup>
1
,</sup><sup>
3
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Uhl%20W%5BAuthor%5D" id="jcmm17825-cr-0009" class="affpopup" co-rid="_co_idm140446572037888" co-class="co-affbox">Waldemar Uhl</a>,<sup>
1
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=M&#x000fc;ller%20T%5BAuthor%5D" id="jcmm17825-cr-0010" class="affpopup" co-rid="_co_idm140446595926048" co-class="co-affbox">Thomas M&#x000fc;ller</a>,<sup>
4
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=M&#x000f6;hler%20H%5BAuthor%5D" id="jcmm17825-cr-0011" class="affpopup" co-rid="_co_idm140446598421632" co-class="co-affbox">Hanns M&#x000f6;hler</a><sup>
5
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140446596167120"><h3 class="no_margin">Britta Majchrzak&#x02010;Stiller</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Majchrzak&#x02010;Stiller%20B%5BAuthor%5D">Britta Majchrzak&#x02010;Stiller</a></div></div><div id="_co_idm140446572200176"><h3 class="no_margin">Marie Buchholz</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Buchholz%20M%5BAuthor%5D">Marie Buchholz</a></div></div><div id="_co_idm140446589759472"><h3 class="no_margin">Ilka Peters</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peters%20I%5BAuthor%5D">Ilka Peters</a></div></div><div id="_co_idm140446593987264"><h3 class="no_margin">Daniel Waschestjuk</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Waschestjuk%20D%5BAuthor%5D">Daniel Waschestjuk</a></div></div><div id="_co_idm140446597409376"><h3 class="no_margin">Johanna Strotmann</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Strotmann%20J%5BAuthor%5D">Johanna Strotmann</a></div></div><div id="_co_idm140446593421568"><h3 class="no_margin">Philipp H&#x000f6;hn</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=H&#x000f6;hn%20P%5BAuthor%5D">Philipp H&#x000f6;hn</a></div></div><div id="_co_idm140446593419072"><h3 class="no_margin">Stephan Hahn</h3><p>
<sup>
2
</sup>
Department of Molecular Gastrointestinal Oncology, 
Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hahn%20S%5BAuthor%5D">Stephan Hahn</a></div></div><div id="_co_idm140446637557104"><h3 class="no_margin">Chris Braumann</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><p>
<sup>
3
</sup>
Department of General, Visceral and Vascular Surgery, Evangelische Kliniken Gelsenkirchen, 
Akademisches Lehrkrankenhaus der Universit&#x000e4;t Duisburg&#x02010;Essen, 
Gelsenkirchen
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Braumann%20C%5BAuthor%5D">Chris Braumann</a></div></div><div id="_co_idm140446572037888"><h3 class="no_margin">Waldemar Uhl</h3><p>
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Uhl%20W%5BAuthor%5D">Waldemar Uhl</a></div></div><div id="_co_idm140446595926048"><h3 class="no_margin">Thomas M&#x000fc;ller</h3><p>
<sup>
4
</sup>
Geistlich Pharma AG, 
Lucerne
Switzerland
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=M&#x000fc;ller%20T%5BAuthor%5D">Thomas M&#x000fc;ller</a></div></div><div id="_co_idm140446598421632"><h3 class="no_margin">Hanns M&#x000f6;hler</h3><p>
<sup>
5
</sup>
Institute of Pharmacology, 
University of Zurich and Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), 
Zurich
Switzerland
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=M&#x000f6;hler%20H%5BAuthor%5D">Hanns M&#x000f6;hler</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140446632210912_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140446632210912_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140446632210912_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140446632210912_ai" style="display:none"><div class="fm-affl" id="jcmm17825-aff-0001">
<sup>
1
</sup>
Department of General and Visceral Surgery, 
St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, 
Bochum
Germany
</div><div class="fm-affl" id="jcmm17825-aff-0002">
<sup>
2
</sup>
Department of Molecular Gastrointestinal Oncology, 
Ruhr&#x02010;University Bochum, 
Bochum
Germany
</div><div class="fm-affl" id="jcmm17825-aff-0003">
<sup>
3
</sup>
Department of General, Visceral and Vascular Surgery, Evangelische Kliniken Gelsenkirchen, 
Akademisches Lehrkrankenhaus der Universit&#x000e4;t Duisburg&#x02010;Essen, 
Gelsenkirchen
Germany
</div><div class="fm-affl" id="jcmm17825-aff-0004">
<sup>
4
</sup>
Geistlich Pharma AG, 
Lucerne
Switzerland
</div><div class="fm-affl" id="jcmm17825-aff-0005">
<sup>
5
</sup>
Institute of Pharmacology, 
University of Zurich and Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), 
Zurich
Switzerland
</div><div><span class="fm-affl">Britta Majchrzak&#x02010;Stiller, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.bur@kazrhcjam.attirb" class="oemail">ed.bur@kazrhcjam.attirb</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="correspondenceTo"><sup>*</sup>

<strong>Correspondence</strong>
<br />
Britta Majchrzak&#x02010;Stiller, Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Ruhr&#x02010;University Bochum, Gudrunstrasse 44791, Germany.<br />
Email: <a href="mailto:dev@null" data-email="ed.bur@kazrhcjam.attirb" class="oemail">ed.bur@kazrhcjam.attirb</a>
<br />
</div><div id="jcmm17825-note-0001">Britta Majchrzak&#x02010;Stiller and Marie Buchholz contributed equally.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140446632210912_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2022 Dec 14; Revised 2023 Jun 14; Accepted 2023 Jun 16.</div></div><div class="permissions half_rhythm hide" id="idm140446632210912_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 The Authors. <em>Journal of Cellular and Molecular Medicine</em> published by Foundation for Cellular and Molecular Medicine and John Wiley &#x00026; Sons Ltd.</div><div class="license half_rhythm">This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-length="88" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">The data presented in this study are available on request from the corresponding author.</p></dd></dl></div><div id="abstract-a.j.b.x" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.j.b.xtitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">GP&#x02010;2250, a novel anticancer agent, severely limits the energy metabolism, as demonstrated by the inhibition of hexokinase 2 and glyceraldehyde&#x02010;3&#x02010;phosphate dehydrogenase and a decrease of ATP. Rescue experiments with supplementary pyruvate or oxaloacetate demonstrated that a TCA cycle deficit largely contributed to cytotoxicity. Activation of the energy&#x02010;deficit sensor, AMP&#x02010;dependent protein kinase, was associated with increased phosphorylation of acetyl&#x02010;CoA carboxylase and Raptor, pointing to a possible deficit in the synthesis of fatty acids and proteins as essential cell components. Binding of p65 to DNA was dose&#x02010;dependently reduced in nuclear lysates. A transcriptional deficit of NF&#x02010;&#x003ba;B (nuclear factor kappa&#x02010;light&#x02010;chain&#x02010;enhancer of activated B cells) was substantiated by the downregulation of cyclin D1 and of the anti&#x02010;apoptotic Bcl2, in line with reduction in tumour cell proliferation and induction of apoptosis, respectively. The upregulation of p53 concomitant with an excess of ROS supported apoptosis. Thus, the anticancer activity of GP&#x02010;2250 is a result of disruption of energy metabolism and inhibition of tumour promotion by NF&#x02010;&#x003ba;B.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">aerobic glycolysis, apoptosis, GP&#x02010;2250, NF&#x003ba;B, pancreatic cancer, proliferation, ROS</span></div></div><div id="jcmm17825-sec-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0001title">1. INTRODUCTION</h2><p class="p p-first">The oxathiazinane compound GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0001" rid-ob="ob-jcmm17825-fig-0001" co-legend-rid="lgnd_jcmm17825-fig-0001"><span>1A</span></a>) is a highly effective antineoplastic agent, as has been demonstrated for pancreatic adenocarcinoma in vitro and in vivo.<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a>, <a href="#jcmm17825-bib-0002" rid="jcmm17825-bib-0002" class=" bibr popnode">
<sup>2</sup>
</a> GP&#x02010;2250 inhibited tumour cell proliferation and induced apoptotic cytotoxicity. In vivo, the growth of patient&#x02010;derived pancreatic tumour tissue was strongly inhibited in xenograft mouse models.<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a>, <a href="#jcmm17825-bib-0002" rid="jcmm17825-bib-0002" class=" bibr popnode">
<sup>2</sup>
</a> GP&#x02010;2250 is presently in a clinical trial for the treatment of pancreatic cancer (<a id="__tag_1137998992" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03854110" ref="reftype=extlink-clinical-trial&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT 03854110","term_id":"NCT03854110"}}</span>NCT 03854110</a>).<a href="#jcmm17825-bib-0003" rid="jcmm17825-bib-0003" class=" bibr popnode">
<sup>3</sup>
</a> Its molecular mechanism of action, however, has remained unclear.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0001" co-legend-rid="lgnd_jcmm17825-fig-0001"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/" target="figure" rid-figpopup="jcmm17825-fig-0001" rid-ob="ob-jcmm17825-fig-0001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446634917248"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g002.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446634917248"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0001"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/" target="figure" rid-figpopup="jcmm17825-fig-0001" rid-ob="ob-jcmm17825-fig-0001">FIGURE 1</a></div><!--caption a7--><div class="caption"><p>Impact of GP&#x02010;2250 on ATP level. Structure of GP&#x02010;2250 (A). Decrease of ATP in BxPC3 cells and (B) Panc Tul cells (C) compared to cell viability (MTT test) following incubation with GP&#x02010;2250 (250 and 500&#x02009;&#x003bc;M) for 6&#x02009;h. The level of ATP and cell viability were assessed in the same test samples. MTT, 3&#x02010;(4,5&#x02010;dimethylthiazol&#x02010;2&#x02010;yl)&#x02010;2,5 diphenyltetrazoliumbromid; NC, negative control.**<em>p</em>&#x02009;&#x02264;&#x02009;0.01; ***<em>p</em>&#x02009;&#x02264;&#x02009;0.001.</p></div></div></div><p>As GP&#x02010;2250 showed comparable antineoplastic activity in pancreatic and mesothelioma tumour cell lines,<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a>, <a href="#jcmm17825-bib-0004" rid="jcmm17825-bib-0004" class=" bibr popnode">
<sup>4</sup>
</a> GP&#x02010;2250 was expected to target a common feature of cancer cells such as aerobic glycolysis, a hallmark of cancer metabolism.<a href="#jcmm17825-bib-0005" rid="jcmm17825-bib-0005" class=" bibr popnode">
<sup>5</sup>
</a>, <a href="#jcmm17825-bib-0006" rid="jcmm17825-bib-0006" class=" bibr popnode">
<sup>6</sup>
</a>, <a href="#jcmm17825-bib-0007" rid="jcmm17825-bib-0007" class=" bibr popnode">
<sup>7</sup>
</a> As the first step in glycolysis, hexokinase (HK) was a potential target for GP&#x02010;2250, with HK2 being highly expressed in cancer cells. HK2 couples metabolic and proliferative effects by rewiring metabolism to aerobic glycolysis and protects against pro&#x02010;apoptotic stimuli by docking to mitochondria.<a href="#jcmm17825-bib-0008" rid="jcmm17825-bib-0008" class=" bibr popnode">
<sup>8</sup>
</a> Glyceraldehyde&#x02010;3&#x02010;phosphate dehydrogenase (GAPDH) is the rate&#x02010;limiting enzyme of aerobic glycolysis thereby exerting control over glycolytic energy metabolism.<a href="#jcmm17825-bib-0009" rid="jcmm17825-bib-0009" class=" bibr popnode">
<sup>9</sup>
</a> Tumour cells contain functional mitochondria<a href="#jcmm17825-bib-0005" rid="jcmm17825-bib-0005" class=" bibr popnode">
<sup>5</sup>
</a>, <a href="#jcmm17825-bib-0007" rid="jcmm17825-bib-0007" class=" bibr popnode">
<sup>7</sup>
</a> and inhibition of the trichloroacetic acid cycle (TCA cycle) can likewise contribute to an energy deficit either as a downstream consequence of the impaired glycolysis or by direct inhibition of TCA cycle enzymes such as &#x003b1;&#x02010;ketoglutarate dehydrogenase (&#x003b1;KGDH).</p><p class="p p-last">Inhibition of glycolytic enzymes and TCA cycle by GP&#x02010;2250 would be expected to reduce ATP and trigger an energy crisis. Activation of the energy&#x02010;deficit sensor, adenosine monophosphate&#x02010;dependent protein kinase (AMPK), suppresses tumour growth<a href="#jcmm17825-bib-0010" rid="jcmm17825-bib-0010" class=" bibr popnode">
<sup>10</sup>
</a> by introducing a metabolic austerity programme via inhibition of downstream ATP&#x02010;consuming biosynthetic pathways.<a href="#jcmm17825-bib-0011" rid="jcmm17825-bib-0011" class=" bibr popnode">
<sup>11</sup>
</a>, <a href="#jcmm17825-bib-0012" rid="jcmm17825-bib-0012" class=" bibr popnode">
<sup>12</sup>
</a> They include the synthesis of fatty acids, proteins and nucleotides, key building blocks for cell growth and proliferation. Tumour growth can also be limited by inhibition of the transcription factor NF&#x02010;&#x003ba;B (nuclear factor kappa&#x02010;light&#x02010;chain&#x02010;enhancer of activated B cells), a major driver of tumour progression with a key impact on cell cycle regulation and apoptosis. Its inhibition would be expected to downregulate the expression of cyclin D1, the driver of mitosis, and Bcl2, an anti&#x02010;apoptotic survival factor.<a href="#jcmm17825-bib-0013" rid="jcmm17825-bib-0013" class=" bibr popnode">
<sup>13</sup>
</a> The drug&#x02010;induced oxidative reactive oxygen species (ROS) stress can be expected to upregulate the transcription factor p53, which provides additional anti&#x02010;tumour activity. Thus, by targeting energy metabolism and the NF&#x02010;&#x003ba;B pathway of tumour cells, GP&#x02010;2250 would be expected to display a dual approach to cytotoxicity.</p></div><div id="jcmm17825-sec-0002" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0002title">2. MATERIALS AND METHODS</h2><div id="jcmm17825-sec-0003" class="sec sec-first"><h3 id="jcmm17825-sec-0003title">2.1. Cell lines and culture conditions</h3><p class="p p-first-last">Two human pancreatic cancer cell lines were used: BxPC3<a href="#jcmm17825-bib-0014" rid="jcmm17825-bib-0014" class=" bibr popnode">
<sup>14</sup>
</a> (ATCC&#x02014;LGC Standards GmbH) and Panc TuI (ATCC&#x02014;LGC Standards GmbH). Authentication was analysed by STR analysis. Panc TuI cells<a href="#jcmm17825-bib-0015" rid="jcmm17825-bib-0015" class=" bibr popnode">
<sup>15</sup>
</a> were cultured in Dulbecco's Modified Eagle Medium (DMEM 25&#x02009;mM Glucose). BxPC3 were maintained in RPMI 1640. Both cultures were supplemented with the antibiotics penicillin (100&#x02009;U/mL), streptomycin (100&#x02009;U/mL) and 2&#x02009;mM&#x02009;L&#x02010;glutamine. Cells were grown as monolayer and cultured in 25&#x02009;cm<sup>2</sup> flasks at 37&#x000b0;C and 5% CO<sub>2</sub> in a humidified atmosphere.</p></div><div id="jcmm17825-sec-0004" class="sec"><h3 id="jcmm17825-sec-0004title">2.2. Western blot analysis</h3><p class="p p-first-last">Protein isolation for western blotting<a href="#jcmm17825-bib-0016" rid="jcmm17825-bib-0016" class=" bibr popnode">
<sup>16</sup>
</a> was carried out by RIPA (radioimmunoprecipitation assay) lysis (Abcam) and the BCA (bicinchoninic acid) assay (Thermo scientific). After loading equal amounts of protein per lane (30&#x02009;&#x003bc;g protein), 7%&#x02013;20% PROTEAN&#x02010;TGX (Tris&#x02010;Glycine eXtended) gels (BIO RAD), were electrophoresed at 250&#x02009;V for 30&#x02013;45&#x02009;min and transferred on to a Trans&#x02010;Blot Turbo PVDF (polyvinylidenfluorid) membrane (BIO RAD) using a Trans&#x02010;Blot Turbo system (BIO RAD). Thereafter, the membranes were blocked in EveryBlot Blocking Buffer (BIO RAD) according to the manufacturer's antibody specification protocol for 5&#x02009;min and incubated overnight at 4&#x000b0;C with the respective primary antibody [P&#x02010;AMPKalpha Rabbit mAB (T172) #2535, P&#x02010;ACC (Ser79) Rabbit mAB #11818, P&#x02010;Raptor (Ser792) Rabbit mAB #2083, p53 Rabbit mAB #2527, mTOR Rabbit Ab #2972, Akt Rabbit Ab #9272, cyclin D1 Rabbit mAB #55506, beta&#x02010;actin Rabbit mAB #8457, &#x003b1;&#x02010;tubulin Rabbit mAb #2125, Bcl2 Rabbit mAb #4223 and BAX Rabbit AB #2772 (CST)] at 1:1000 dilution. The membranes were washed using PBST (phosphate buffered saline&#x02009;+&#x02009;tween 0.025%) and incubated with an Anti&#x02010;rabbit IgG HRP&#x02010;linked AB 7074; (1:2000 CST). ChemiDoc MP Imaging System (BIO RAD) was used for band detection. Western blots were done in triplicate and representative blots are depicted.</p></div><div id="jcmm17825-sec-0005" class="sec"><h3 id="jcmm17825-sec-0005title">2.3. 
<span style="fixed-case">ATP</span> and cell viability determination</h3><p class="p p-first-last">The ATP level in the cell lines was measured using the Luminescent ATP Detection Assay Kit (Abcam; ab1113849) following the manufacturer's instructions. The viability of cells was determined with the MTT assay as described earlier.<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a> The assay was performed in at least three independent experiments with consecutive passages.</p></div><div id="jcmm17825-sec-0006" class="sec"><h3 id="jcmm17825-sec-0006title">2.4. HK2 assay</h3><p class="p p-first-last">A HK activity assay kit (Merck, D, MAK091&#x02010;1KT)<a href="#jcmm17825-bib-0017" rid="jcmm17825-bib-0017" class=" bibr popnode">
<sup>17</sup>
</a> was used following the manufacturer's instructions. Cells were incubated with different concentrations of GP&#x02010;2250 for 24&#x02009;h before lysis. To analyse HK2 activity, lysates were partly incubated for 1&#x02009;h at 45&#x000b0;C to eliminate HK2, which is sensitive to temperature. The difference between total HK activity (lysates on ice) and HK 1 activity (lysates for 1&#x02009;h at 45&#x000b0;C) reveals the activity of HK2.</p></div><div id="jcmm17825-sec-0007" class="sec"><h3 id="jcmm17825-sec-0007title">2.5. 
<span style="fixed-case">rh</span>HK2 enzyme activity assay</h3><p class="p p-first-last">Recombinant human hexokinase 2 (rhHK2) enzyme activity was tested in vitro using HK2 from a HK2 inhibitor assay kit (Abcam, ab211114) following the manufacturer's instructions.</p></div><div id="jcmm17825-sec-0008" class="sec"><h3 id="jcmm17825-sec-0008title">2.6. 
<span style="fixed-case">GAPDH</span> enzyme activity assay</h3><p class="p p-first-last">Following incubation with GP&#x02010;2250 for 24&#x02009;h, cell lysates were prepared in lysis buffer [20&#x02009;mM Tris (tris [hydroxymethyl] aminomethane) pH&#x02009;7.8, 100&#x02009;mM NaCL, 1% triton, protease inhibitors] followed by centrifugation. Enzyme activity was measured from 10&#x02009;&#x003bc;L of cell lysate as described by Kornberg et al.<a href="#jcmm17825-bib-0018" rid="jcmm17825-bib-0018" class=" bibr popnode">
<sup>18</sup>
</a> Assays were performed in 10&#x02009;mM sodium pyrophosphate buffer (pH&#x02009;8.5) in 96&#x02010;well plates. Cell lysates were incubated with 20&#x02009;mM sodium arsenate (made fresh on the day of experiment), 1&#x02009;mM NAD+, and 2.88&#x02009;mM glyceraldehyde&#x02010;3&#x02010;phosphate (G3P). Enzyme activity was measured using a microplate reader&#x02014;spectrophotometer (Tecan) as the increase in absorbance at 340&#x02009;nm is due to the reduction of NAD+. The assay was performed at 37&#x000b0;C. The lysate was first diluted into sodium pyrophosphate buffer to a volume of 100&#x02009;&#x003bc;L. An additional 100&#x02009;&#x003bc;L of reaction mix containing the sodium arsenate, NAD+ and G3P was added. Absorbance was measured every 5&#x02009;min for 60&#x02009;min.</p></div><div id="jcmm17825-sec-0009" class="sec"><h3 id="jcmm17825-sec-0009title">2.7. 
<span style="fixed-case">rhGAPDH</span> enzyme activity assay</h3><p class="p p-first-last">Recombinant human GAPDH (rhGAPDH) (Abcam, ab 82633) was used. 2&#x02009;&#x003bc;g of rhGAPDH was transferred to HEN buffer (250&#x02009;mM Hepes&#x02010;NaOH, 1&#x02009;mM EDTA 0 and 1&#x02009;mM neocuproine) and incubated with PBS or GP&#x02010;2250 (100 and 250&#x02009;&#x003bc;M) at 37&#x000b0;C. After 0, 30 and 60&#x02009;min of incubation, an aliquot was taken for the enzyme assay. The assay was conducted using the GAPDH Activity Assay Kit (Abcam Cambridge, UK, ab204732) following the manufacturer's instructions.<a href="#jcmm17825-bib-0019" rid="jcmm17825-bib-0019" class=" bibr popnode">
<sup>19</sup>
</a>
</p></div><div id="jcmm17825-sec-0010" class="sec"><h3 id="jcmm17825-sec-0010title">2.8. 
<span style="fixed-case">PDH</span> enzyme activity assay</h3><p class="p p-first-last">A pyruvate dehydrogenase (PDH) activity assay kit (Merck, D, MAK183&#x02010;1KT) was used following the manufacturer's instructions. Cells were incubated with different concentrations of GP&#x02010;2250 for 24&#x02009;h before lysis.</p></div><div id="jcmm17825-sec-0011" class="sec"><h3 id="jcmm17825-sec-0011title">2.9. 
<span style="fixed-case">&#x003b1;KGDH</span> activity assay</h3><p class="p p-first-last">An &#x003b1;&#x02010;ketoglutarate dehydrogenase (&#x003b1;KGDH) Activity Assay Kit (Merck, D, MAK189&#x02010;1KT) was used following the manufacturer's instructions.<a href="#jcmm17825-bib-0020" rid="jcmm17825-bib-0020" class=" bibr popnode">
<sup>20</sup>
</a> Cells were incubated with different concentrations of GP&#x02010;2250 for 24&#x02009;h before lysis.</p></div><div id="jcmm17825-sec-0012" class="sec"><h3 id="jcmm17825-sec-0012title">2.10. Rescue experiments with pyruvate and oxaloacetate</h3><p class="p p-first-last">Cells were incubated with different concentrations of GP&#x02010;2250 for 24&#x02009;h in culture medium supplemented or not supplemented with either pyruvate (PYR) (5&#x02009;mM in DMEM with 2&#x02009;mM Glucose) or oxaloacetate (OAA) (5&#x02009;mM in DMEM with 25&#x02009;mM Glucose). The viability of cells was determined with the MTT assay as described earlier.<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a> The assay was performed in at least three independent experiments with consecutive passages.</p></div><div id="jcmm17825-sec-0013" class="sec"><h3 id="jcmm17825-sec-0013title">2.11. 
<span style="fixed-case">ROS</span> assay</h3><p class="p p-first-last">ROS was analysed using the Cellular ROS/Superoxide Detection Assay Kit (ab139476, Abcam)<a href="#jcmm17825-bib-0021" rid="jcmm17825-bib-0021" class=" bibr popnode">
<sup>21</sup>
</a> following the manufacturer's instructions.</p></div><div id="jcmm17825-sec-0014" class="sec"><h3 id="jcmm17825-sec-0014title">2.12. 
<span style="fixed-case">NF&#x02010;&#x003ba;B</span> transcription factor binding assay</h3><p class="p p-first-last">The transcription factor NF&#x02010;&#x003ba;B was assayed with the NF&#x003ba;B p65 Transcription Factor Assay Kit (Abcam, ab133112)<a href="#jcmm17825-bib-0022" rid="jcmm17825-bib-0022" class=" bibr popnode">
<sup>22</sup>
</a> following the manufacturer's instructions. Lysates were prepared either from drug&#x02010;treated cells or, alternatively, from untreated cells with the lysates being directly incubated with GP&#x02010;2250. The nuclear extracts were prepared with the Nuclear Extraction Kit (Abcam, ab113474) according to the manufacturer's instructions.</p></div><div id="jcmm17825-sec-0015" class="sec sec-last"><h3 id="jcmm17825-sec-0015title">2.13. Statistics and calculations</h3><p class="p p-first-last">Results of MTT test, ATP assay, ROS assay, HK2 assay, GAPDH assay, PDH assay, NF&#x02010;&#x003ba;B assay, western blots and rescue experiments are expressed as mean &#x000b1; SD. Comparison between experimental groups with normal distribution was performed using one&#x02010;way <span class="small-caps">anova</span> followed by Tukey's post hoc test and pairwise tests performed using <em>t</em>&#x02010;tests. <em>p</em>&#x02009;&#x02264;&#x02009;0.05 were considered statistically significant and indicated in the figures as follows: *<em>p</em>&#x02009;&#x02264;&#x02009;0.05; **<em>p</em>&#x02009;&#x02264;&#x02009;0.01; ***<em>p</em>&#x02009;&#x02264;&#x02009;0.001.</p></div></div><div id="jcmm17825-sec-0016" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0016title">3. RESULTS</h2><div id="jcmm17825-sec-0017" class="sec sec-first"><h3 id="jcmm17825-sec-0017title">3.1. Induction of energy deficiency</h3><p class="p p-first-last">The hypothesis that GP&#x02010;2250 induces an energy deficit was tested by measuring the level of ATP in the pancreatic tumour cell lines BxPC3 and Panc Tul. At the lowest dose tested (250&#x02009;&#x003bc;M GP&#x02010;2250), a significant decrease in ATP was already apparent at 6&#x02009;h in both BxPC3 and Panc Tul cells (12.4%&#x02009;&#x000b1;&#x02009;2.4% and 19.8%&#x02009;&#x000b1;&#x02009;2.3%, respectively), with no loss of cell viability (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0001" rid-ob="ob-jcmm17825-fig-0001" co-legend-rid="lgnd_jcmm17825-fig-0001"><span>1B,C</span></a>). A further decrease in ATP was apparent at the same time point with 500&#x02009;&#x003bc;M GP&#x02010;2250 in both cell lines (32.5%&#x02009;&#x000b1;&#x02009;3.1% and 48.9%&#x02009;&#x000b1;&#x02009;4.8%, respectively), at which dose only a minor decrease of cell viability of 10%&#x02013;12% was observed (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0001" rid-ob="ob-jcmm17825-fig-0001" co-legend-rid="lgnd_jcmm17825-fig-0001"><span>1B,C</span></a>). These findings of a drug&#x02010;induced deficit of ATP pointed to an inhibition of energy metabolism by GP&#x02010;2250.</p></div><div id="jcmm17825-sec-0018" class="sec"><h3 id="jcmm17825-sec-0018title">3.2. Cytotoxicity by inhibition of glycolytic enzymes and the <span style="fixed-case">TCA</span> cycle</h3><p class="p p-first">To assess the impact of GP&#x02010;2250 on glucose metabolism, HK2 and GAPDH activity was tested. HK2 was inhibited by 40.7%&#x02009;&#x000b1;&#x02009;2.9% and 18.1%&#x02009;&#x000b1;&#x02009;1.4% following the incubation of Panc Tul and BxPC3 cells, respectively, with GP&#x02010;2250 (500&#x02009;&#x003bc;M) and further inhibited at higher concentrations (750, 1000&#x02009;&#x003bc;M) (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2D</span></a>). Similarly, human recombinant HK2 was inhibited by 80.8% and 81.5% versus control following incubation for 60&#x02009;min with 250 and 500&#x02009;&#x003bc;M GP&#x02010;2250, respectively. (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2C</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446596991808"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g004.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g004.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g004.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446596991808"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0002"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002">FIGURE 2</a></div><!--caption a7--><div class="caption"><p>Inhibition of glycolytic and TCA cycle&#x02010;related enzymes. (A) Recombinant human GAPDH treated with 100 and 250&#x02009;&#x003bc;M GP&#x02010;2250 for 30 and 60&#x02009;min, followed by GAPDH enzyme activity assay. (B) Inhibition of GAPDH activity in Panc Tul and BxPC3 cells following incubation with GP&#x02010;2250 (500&#x02009;&#x003bc;M) for 24&#x02009;h. The GAPDH inhibitor DMF, 100&#x02009;&#x003bc;M, was included as control. (C) Human recombinant hexokinase 2 (HK2) incubated with 250 and 500&#x02009;&#x003bc;M GP&#x02010;2250 for 60&#x02009;min. Formation of NADH was measured every 5&#x02009;min. (D) Inhibition of hexokinase 2 (HK2)activity in Panc Tul and BxPC3 cells following incubation with GP&#x02010;2250 (250, 500 and 1000&#x02009;&#x003bc;M) for 24&#x02009;h. (E) Inhibition of alpha&#x02010;ketoglutarate dehydrogenase (&#x003b1;KGDH) following treatment of Panc Tul and BxPC3 cells for 24&#x02009;h with GP&#x02010;2250 (250, 500 and 1000&#x02009;&#x003bc;M). (F) Inhibition of pyruvate dehydrogenase (PDH) following treatment of Panc Tul and BxPC3 cells for 24&#x02009;h with GP&#x02010;2250 (250 and 500&#x02009;&#x003bc;M). Concentrations of GP&#x02010;2250 ranging from 100 to 1000&#x02009;&#x003bc;M were used in the cellular assays of GAPDH, HK2, &#x003b1;KGDH and PDH, Shown are the results of the lowest effective concentrations, respectively. *<em>p</em>&#x02009;&#x02264;&#x02009;0.05, significant; **<em>p</em>&#x02009;&#x02264;&#x02009;0.01, highly significant; ***<em>p</em>&#x02009;&#x02264;&#x02009;0.001, extremely significant. DMF, dimethylfumarate; GAPDH, glyceraldehyde&#x02010;3&#x02010;phosphate&#x02010;dehydrogenase; HK2, hexokinase 2; NADH, nicotinamide adenine dinucleotide&#x02009;+&#x02009;hydrogen; NC, negative control; U, untreated.</p></div></div></div><p>GAPDH was inhibited by 30.9%&#x02009;&#x000b1;&#x02009;1.3% and 34.7%&#x02009;&#x000b1;&#x02009;2.3% following the incubation of Panc Tul and BxPC3 cells, respectively, with GP&#x02010;2250 (500&#x02009;&#x003bc;M) (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2B</span></a>). The selective GAPDH inhibitor dimethylfumarate (DMF) was included as reference.<a href="#jcmm17825-bib-0018" rid="jcmm17825-bib-0018" class=" bibr popnode">
<sup>18</sup>
</a> Likewise, recombinant human GAPDH (rhGAPDH) activity was reduced by 20% and 40%, respectively, versus control following incubation for 30&#x02009;min with 100 and 250&#x02009;&#x003bc;M GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2A</span></a>). Inhibition of rhGAPDH was further increased at 60&#x02009;min incubation, although the measurements were impacted by the known natural loss of activity of rhGAPDH. Besides HK2 and GAPDH, PDH and &#x003b1;KGDH were dose&#x02010;dependently inhibited by GP&#x02010;2250. PDH was reduced by 11.6%&#x02009;&#x000b1;&#x02009;0.6% at 250&#x02009;&#x003bc;M and 22.4%&#x02009;&#x000b1;&#x02009;0.3% at 500&#x02009;&#x003bc;M in Panc TuI; 9.3%&#x02009;&#x000b1;&#x02009;1.8% at 250&#x02009;&#x003bc;M and 19.8%&#x02009;&#x000b1;&#x02009;4.6% at 500&#x02009;&#x003bc;M in BxPC3 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2F</span></a>). &#x003b1;KGDH was reduced by 8.6%&#x02009;&#x000b1;&#x02009;0.2% at 250&#x02009;&#x003bc;M; 25.7%&#x02009;&#x000b1;&#x02009;0.0% at 500&#x02009;&#x003bc;M and 48.2%&#x02009;&#x000b1;&#x02009;0.1% at 1000&#x02009;&#x003bc;M in Panc TuI; 13.6%&#x02009;&#x000b1;&#x02009;1.8% at 250&#x02009;&#x003bc;M; 24.1%&#x02009;&#x000b1;&#x02009;1.6% at 500&#x02009;&#x003bc;M and 40.9%&#x02009;&#x000b1;&#x02009;0.75% at 1000&#x02009;&#x003bc;M in BxPC3 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2E</span></a>).</p><p class="p">Rescue experiments with the TCA cycle components OAA and PYR supported the view that the energy deficit was causal for the cytotoxicity. Addition of OAA as a supplementary substrate strongly reduced the cytotoxicity over the entire concentration range of GP&#x02010;2250 (200&#x02013;1000&#x02009;&#x003bc;M) in both Panc Tul and BxPC3 cell lines (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003" co-legend-rid="lgnd_jcmm17825-fig-0003"><span>3A</span></a>,B). Addition of PYR likewise reduced the cytotoxicity of GP&#x02010;2250 to a large extent over the entire active drug concentration range tested (300&#x02013;1000&#x02009;&#x003bc;M) (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003" co-legend-rid="lgnd_jcmm17825-fig-0003"><span>3C,D</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0003" co-legend-rid="lgnd_jcmm17825-fig-0003"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446598502080"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g001.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446598502080"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0003"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003">FIGURE 3</a></div><!--caption a7--><div class="caption"><p>Rescue from GP&#x02010;2250&#x02010;induced cytotoxicity by oxaloacetate or pyruvate. (A) Panc Tul and (B) BxPC3 cells treated with different concentrations of GP&#x02010;2250 (50&#x02013;1000&#x02009;&#x003bc;M) for 24&#x02009;h in the absence (black columns) or presence (white columns) of supplementary oxaloacetate (OAA, 5&#x02009;mM). (C) Panc Tul and (D) BxPC3 cells were treated with different concentrations of GP&#x02010;2250 (100&#x02013;1000&#x02009;&#x003bc;M) for 24&#x02009;h in the absence (black columns) or presence (white columns) of pyruvate (PYR 5&#x02009;mM). Cell viability was tested with MTT. There was major significant protection from GP&#x02010;2250&#x02010;induced cytotoxicity by OAA and PYR nearly over the entire range of active drug concentrations. NC, negative control. *<em>p</em>&#x02009;&#x02264;&#x02009;0.05, significant; **<em>p</em>&#x02009;&#x02264;&#x02009;0.01, highly significant; ***<em>p</em>&#x02009;&#x02264;&#x02009;0.001, extremely significant.</p></div></div></div></div><div id="jcmm17825-sec-0019" class="sec"><h3 id="jcmm17825-sec-0019title">3.3. Generation of <span style="fixed-case">ROS</span>
</h3><p class="p p-first">In both Panc Tul and BxPC3 cells, a strong rise in ROS was already apparent after 90&#x02009;min of incubation with higher concentrations of GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004" co-legend-rid="lgnd_jcmm17825-fig-0004"><span>4A,B</span></a>). Addition of the reducing agent NAC (<span class="small-caps">n</span>&#x02010;acetylcysteine) abrogated the rise in ROS as shown by the negative control (NC). The ROS level was slightly higher in the untreated control (UC), which was devoid of NAC, a finding which presumably reflects the ROS base level in the cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0004" co-legend-rid="lgnd_jcmm17825-fig-0004"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446598538480"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g003.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446598538480"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0004"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004">FIGURE 4</a></div><!--caption a7--><div class="caption"><p>Generation of ROS and inhibition of NF&#x02010;&#x003ba;B. Generation of ROS in Panc TuI (A) and BxPC3 (B) cells following incubation with various concentrations of GP&#x02010;2250 for 90&#x02009;min compared to an untreated control (UC). Negative control (NC) contained NAC (5&#x02009;mM) in the presence of 1000&#x02009;&#x003bc;M GP&#x02010;2250. Inhibition of NF&#x02010;kB (C, D) p65/DNA binding was dose&#x02010;dependently inhibited following incubation of Panc Tul and BxPC3 cells with GP&#x02010;2250 (250&#x02013;1000&#x02009;&#x003bc;M) for 24&#x02009;h, as tested in lysates of the nuclear fraction. Bay 117082 (10&#x02009;&#x003bc;M) served as control. (E, F) p65/DNA binding in lysates of the nuclear fraction from untreated Panc TuI and BxPC3 cells incubated directly with GP&#x02010;2250 (250, 500 and 1000&#x02009;&#x003bc;M). C, non&#x02010;treated control; NAC, <span class="small-caps">n</span>&#x02010;acetylcysteine; NC, negative control; NF&#x02010;&#x003ba;B, nuclear factor kappa&#x02010;light&#x02010;chain&#x02010;enhancer of activated B cells; ROS, reactive oxygen species; SD, standard deviation; UC, untreated control. *<em>p</em>&#x02009;&#x02264;&#x02009;0.05, significant; **<em>p</em>&#x02009;&#x02264;&#x02009;0.01, highly significant; ***<em>p</em>&#x02009;&#x02264;&#x02009;0.001, extremely significant.</p></div></div></div></div><div id="jcmm17825-sec-0020" class="sec"><h3 id="jcmm17825-sec-0020title">3.4. Activation of <span style="fixed-case">AMPK</span>
</h3><p class="p p-first">The energy deficit induced by GP&#x02010;2250 was expected to activate the metabolic regulator AMPK through phosphorylation at threonine 172 (Thr 172) by an upstream kinase.<a href="#jcmm17825-bib-0011" rid="jcmm17825-bib-0011" class=" bibr popnode">
<sup>11</sup>
</a>, <a href="#jcmm17825-bib-0012" rid="jcmm17825-bib-0012" class=" bibr popnode">
<sup>12</sup>
</a> In the presence of GP&#x02010;2250, the phosphorylation of AMPK at Thr 172 was increased in a time&#x02010;dependent manner (6&#x02013;24&#x02009;h) as tested in PancTul cells (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><span>5A</span></a>). The dose&#x02010;dependency in the range of 250&#x02013;1000&#x02009;&#x003bc;M was determined in BxPC3 cells (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><span>5B</span></a>). To test whether the activation of AMPK was functionally significant, two downstream targets were analysed, acetyl&#x02010;CoA carboxylase (ACC) and Raptor.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446569995712"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g007.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g007.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g007.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446569995712"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0005"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005">FIGURE 5</a></div><!--caption a7--><div class="caption"><p>Representative western blot (A) and quantitative analysis (B) of pAMPK and cyclin D1. pAMPK: Time dependency of AMPK phosphorylation at T172 following incubation of Panc Tul with GP&#x02010;2250 (250&#x02009;&#x003bc;M).) Dose&#x02010;dependency of AMPK phosphorylation after incubation of BxPC3 cells+ for 24&#x02009;h. Cyclin D1: Time&#x02010;dependent decrease of cyclin D1 following incubation of Panc Tul (500&#x02009;&#x003bc;M GP&#x02010;2250) and BxPC3 cells (250&#x02009;&#x003bc;M GP&#x02010;2250). &#x000df;&#x02010;Actin/HSP&#x02010;90 used as internal controls. NC, negative control.</p></div></div></div></div><div id="jcmm17825-sec-0021" class="sec"><h3 id="jcmm17825-sec-0021title">3.5. Phosphorylation of the rate&#x02010;limiting enzyme of fatty acid synthesis and Raptor</h3><p class="p p-first">The enzyme ACC, the rate&#x02010;limiting step of fatty acid synthesis, is susceptible to AMPK&#x02010;induced inhibition through phosphorylation at serine 79 (Ser79). In the presence of GP&#x02010;2250, ACC&#x02010;1 was increasingly phosphorylated at Ser79 over time, which was apparent for both Panc TuI (250&#x02009;&#x003bc;M) and BxPC3 (500&#x02009;&#x003bc;M), as tested by western blotting (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). The phosphorylation was somewhat more prominent at 12&#x02009;h than at 24&#x02009;h. The phosphorylation of ACC&#x02010;1 points to a potential impact of GP&#x02010;2250 on fatty acid synthesis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446596998448"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g006.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g006.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g006.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446596998448"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0006"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006">FIGURE 6</a></div><!--caption a7--><div class="caption"><p>Representative western blot (A) and quantitative analysis (B) of regulatory proteins in Panc TuI (A) and BxPC3 (B) cells. pACC: Time&#x02010;dependent increase of ACC&#x02010;1 phosphorylation at Ser79 and of Raptor at Ser792 following incubation of Panc Tul (250&#x02009;&#x003bc;M GP&#x02010;2250) and BxPC3 (500&#x02009;&#x003bc;M GP&#x02010;2250). pRaptor: Time&#x02010;dependent Raptor phosphorylation at Ser 792 in PancTul and BxPc3 cells incubated with 500 and 1000&#x02009;&#x003bc;M GP&#x02010;2250. p53: Time&#x02010;dependent increase of protein level of p53 in Panc Tul and BxPC3 cells (500&#x02009;&#x003bc;M GP&#x02010;2250). Akt and mTor: Time&#x02010;dependent decrease of the protein level of Akt and mTor at 1000&#x02009;&#x003bc;M GP&#x02010;2250 in Panc TuI and BxPC3 cells. Bcl2: Time&#x02010;dependent downregulation of protein level of Bcl2 following incubation of Panc Tul and BxPC3 cells (500&#x02009;&#x003bc;M GP&#x02010;2250). &#x000df;&#x02010;Actin/HSP&#x02010;90 used as internal controls.</p></div></div></div><p>The mTOR complex 1 (mTORC1) drives cellular growth<a href="#jcmm17825-bib-0023" rid="jcmm17825-bib-0023" class=" bibr popnode">
<sup>23</sup>
</a>, <a href="#jcmm17825-bib-0024" rid="jcmm17825-bib-0024" class=" bibr popnode">
<sup>24</sup>
</a> and can be directly inhibited by AMPK through phosphorylation of its constituent protein Raptor at Ser792.<a href="#jcmm17825-bib-0011" rid="jcmm17825-bib-0011" class=" bibr popnode">
<sup>11</sup>
</a>, <a href="#jcmm17825-bib-0024" rid="jcmm17825-bib-0024" class=" bibr popnode">
<sup>24</sup>
</a>, <a href="#jcmm17825-bib-0025" rid="jcmm17825-bib-0025" class=" bibr popnode">
<sup>25</sup>
</a>, <a href="#jcmm17825-bib-0026" rid="jcmm17825-bib-0026" class=" bibr popnode">
<sup>26</sup>
</a>
</p><p class="p p-last">In the presence of GP&#x02010;2250 (500&#x02009;&#x003bc;M), Raptor phosphorylation at Ser792 was time&#x02010;dependently increased as shown in western blots with Panc TuI cells responding at a lower drug concentration (500&#x02009;&#x003bc;M) than BxPC3 (1000&#x02009;&#x003bc;M) (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). In addition, the mTOR protein level was time&#x02010;dependently reduced in both cell lines by GP&#x02010;2250 (1000&#x02009;&#x003bc;M) (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). The protein level of the upstream serine/threonine&#x02010;kinase Akt, a driver of tumour proliferation, was likewise time&#x02010;dependently decreased by GP&#x02010;2250 (1000&#x02009;&#x003bc;M) in both cell lines (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). These results point to a possible inhibition of cell growth by GP&#x02010;2250.</p></div><div id="jcmm17825-sec-0022" class="sec"><h3 id="jcmm17825-sec-0022title">3.6. Inhibition of the <span style="fixed-case">NF&#x02010;&#x003ba;B</span> and its transcriptional activity</h3><p class="p p-first">To test whether GP&#x02010;2250 might inhibit the NF&#x02010;kB pathway, p65/DNA binding was analysed in nuclear lysates prepared from Panc Tul and BxPC3 cells, which had been treated for 24&#x02009;h with various concentrations of GP&#x02010;2250. GP&#x02010;2250 caused a concentration&#x02010;dependent inhibition of p65/DNA binding in both cell lines, which was significant already at 250&#x02009;&#x003bc;M and reached 42.1% in Panc TuI (500&#x02009;&#x003bc;M) and 19.7% in BxPC3 (500&#x02009;&#x003bc;M). Bay 117082 served as control<a href="#jcmm17825-bib-0018" rid="jcmm17825-bib-0018" class=" bibr popnode">
<sup>18</sup>
</a> (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004" co-legend-rid="lgnd_jcmm17825-fig-0004"><span>4C,D</span></a>). In addition, when lysates from untreated Panc Tul and BxPC3 cells were incubated with the same concentrations of GP&#x02010;2250, a comparable degree of inhibition of p65/DNA binding was found (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004" co-legend-rid="lgnd_jcmm17825-fig-0004"><span>4E,F</span></a>). This result supports the view that GP&#x02010;2250 is able to directly inhibit p65/DNA binding.</p><p class="p p-last">The inhibition of p65/DNA binding by GP&#x02010;2250 resulted in a reduced expression of the downstream targets cyclin D1 and Bcl2. The expression of cyclin D1 was time&#x02010;dependently (6&#x02009;h to 24&#x02009;h) reduced by GP&#x02010;2250 as shown by western blotting for Panc Tul and BxPC3 cell lines (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><span>5A,B</span></a>), being already apparent after 6&#x02009;h of incubation. The expression of the anti&#x02010;apoptotic protein Bcl2 was likewise reduced in a time&#x02010;dependent manner in Panc Tul and BxPC3 cells as shown by western blotting (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). The time&#x02010;dependent reduction of cyclin D1 expression supports the mitosis&#x02010;inhibitory effect of GP&#x02010;2250<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a> and the Bcl2 deficit is expected to increase apoptosis.</p></div><div id="jcmm17825-sec-0023" class="sec sec-last"><h3 id="jcmm17825-sec-0023title">3.7. Upregulation of p53</h3><p class="p p-first-last">As a response to metabolic and oxidative stress, cells frequently respond by arresting cell division or by inducing apoptosis, triggered by the transcription factor and tumour repressor p53.<a href="#jcmm17825-bib-0027" rid="jcmm17825-bib-0027" class=" bibr popnode">
<sup>27</sup>
</a>, <a href="#jcmm17825-bib-0028" rid="jcmm17825-bib-0028" class=" bibr popnode">
<sup>28</sup>
</a> In the presence of GP&#x02010;2250 (500&#x02009;&#x003bc;M), p53 protein levels were time&#x02010;dependently increased, serving as a sign of activation of the stress response (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>).</p></div></div><div id="jcmm17825-sec-0024" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0024title">4. DISCUSSION</h2><div id="jcmm17825-sec-0025" class="sec sec-first"><h3 id="jcmm17825-sec-0025title">4.1. Inhibition of energy metabolism causes anticancer activity</h3><p class="p p-first">As outlined in a schematic overview (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0007/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0007" rid-ob="ob-jcmm17825-fig-0007" co-legend-rid="lgnd_jcmm17825-fig-0007"><span>7</span></a>), the anticancer agent GP&#x02010;2250 induced global alterations in tumour cell metabolism. Inhibition of glycolysis through inhibition of HK2 and GAPDH appears to be the prime event (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2B,D</span></a>), as these two enzymes are considered to be direct drug targets as demonstrated by the inhibition of the respective recombinant enzymes by GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2A,C</span></a>). At comparable concentrations of GP&#x02010;2250 (500&#x02009;&#x003bc;M), the TCA cycle enzymes &#x003b1;KGDH and PDH were inhibited to a lower degree than HK2 and GAPDH (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0002" rid-ob="ob-jcmm17825-fig-0002" co-legend-rid="lgnd_jcmm17825-fig-0002"><span>2E,F</span></a>), limiting their impact relative due to the inhibition of the upstream glycolysis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="jcmm17825-fig-0007" co-legend-rid="lgnd_jcmm17825-fig-0007"><a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0007/" target="figure" rid-figpopup="jcmm17825-fig-0007" rid-ob="ob-jcmm17825-fig-0007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140446590853920"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g005.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCMM-27-2082-g005.jpg" src="/pmc/articles/PMC10339077/bin/JCMM-27-2082-g005.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140446590853920"><a target="object" rel="noopener" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_jcmm17825-fig-0007"><div><a class="figpopup" href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0007/" target="figure" rid-figpopup="jcmm17825-fig-0007" rid-ob="ob-jcmm17825-fig-0007">FIGURE 7</a></div><!--caption a7--><div class="caption"><p>Proposed scheme of the alteration of cancer cell metabolism and NF&#x02010;&#x003ba;B inhibition by GP&#x02010;2250. Bold black arrows indicate metabolic pathways; red and green arrows indicate drug&#x02010;induced changes. By limiting the energy metabolism through the inhibition of hexokinase 2 and GAPDH, GP&#x02010;2250 induces an energy deficit in line with an impairment of the TCA cycle. The reduction of ATP triggers the activation of the energy&#x02010;deficit sensor AMPK. Its downstream events include the inhibition of mTOR, a major driver of tumour cell growth and potential impairment of fatty acid synthesis (FAS) through ACC&#x02010;1 inhibition. The inhibition of NF&#x02010;&#x003ba;B by GP&#x02010;2250 limits the rate of tumour cell proliferation through cyclin D1 downregulation. It also promotes apoptosis through downregulation of the anti&#x02010;apoptotic Bcl2. ROS contributes to the upregulation of the transcription factor p53, which supports apoptosis. AMPK, adenosine monophosphate&#x02010;dependent protein kinase; FAS, fatty acid synthesis; NF&#x02010;&#x003ba;B, nuclear factor kappa&#x02010;light&#x02010;chain&#x02010;enhancer of activated B cells; PDH, pyruvate dehydrogenase.</p></div></div></div><p>The causative link between the cytotoxicity of GP&#x02010;2250 and the inhibition of the glycolytic enzymes and the TCA cycle was demonstrated in two rescue experiments. The ability of supplementary OAA and PYR to largely rescue tumour cells from drug&#x02010;induced cytotoxicity is evidence that the deficit in glycolytic and TCA cycle&#x02010;dependent energy metabolism is the major cause for the cytotoxicity of GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003" co-legend-rid="lgnd_jcmm17825-fig-0003"><span>3A&#x02013;D</span></a>).</p><p>Both HK2 and GAPDH are upregulated in many human tumours and serve as drug targets.<a href="#jcmm17825-bib-0008" rid="jcmm17825-bib-0008" class=" bibr popnode">
<sup>8</sup>
</a> Inhibitors of HK2 such as benitrobenrazide show anticancer activity as demonstrated in tumour xenograft models<a href="#jcmm17825-bib-0029" rid="jcmm17825-bib-0029" class=" bibr popnode">
<sup>29</sup>
</a> and clinical trials have started with the HK2 inhibitor lonidamine.<a href="#jcmm17825-bib-0008" rid="jcmm17825-bib-0008" class=" bibr popnode">
<sup>8</sup>
</a> Apart from limiting glycolysis, HK2 inhibition is expected to contribute to the rise of ROS by reducing the synthesis of the reducing agent NADPH through inhibition of the pentose phosphate pathway.<a href="#jcmm17825-bib-0005" rid="jcmm17825-bib-0005" class=" bibr popnode">
<sup>5</sup>
</a>, <a href="#jcmm17825-bib-0030" rid="jcmm17825-bib-0030" class=" bibr popnode">
<sup>30</sup>
</a>
</p><p>The selective GAPDH inhibitors koningic acid<a href="#jcmm17825-bib-0009" rid="jcmm17825-bib-0009" class=" bibr popnode">
<sup>9</sup>
</a> and DMF<a href="#jcmm17825-bib-0018" rid="jcmm17825-bib-0018" class=" bibr popnode">
<sup>18</sup>
</a>, <a href="#jcmm17825-bib-0031" rid="jcmm17825-bib-0031" class=" bibr popnode">
<sup>31</sup>
</a> displayed cytotoxicity in a multitude of cancer cell lines in vitro and in vivo, including colon cancer cells,<a href="#jcmm17825-bib-0032" rid="jcmm17825-bib-0032" class=" bibr popnode">
<sup>32</sup>
</a> breast cancer cells,<a href="#jcmm17825-bib-0033" rid="jcmm17825-bib-0033" class=" bibr popnode">
<sup>33</sup>
</a> melanoma cells<a href="#jcmm17825-bib-0034" rid="jcmm17825-bib-0034" class=" bibr popnode">
<sup>34</sup>
</a> and hepatocellular carcinoma.<a href="#jcmm17825-bib-0035" rid="jcmm17825-bib-0035" class=" bibr popnode">
<sup>35</sup>
</a>
</p><p class="p p-last">PDH is the gatekeeper between glycolysis and the TCA cycle,<a href="#jcmm17825-bib-0036" rid="jcmm17825-bib-0036" class=" bibr popnode">
<sup>36</sup>
</a> and the inhibition of the TCA cycle itself by &#x003b1;KGDH inhibition is known to contribute to an energy deficit and support anticancer and anti&#x02010;metastatic activity as shown for the &#x003b1;KGDH inhibitors CPI&#x02010;613 and AA6, respectively.<a href="#jcmm17825-bib-0037" rid="jcmm17825-bib-0037" class=" bibr popnode">
<sup>37</sup>
</a>, <a href="#jcmm17825-bib-0038" rid="jcmm17825-bib-0038" class=" bibr popnode">
<sup>38</sup>
</a> These examples illustrate that the inhibition of aerobic glycolysis and the TCA cycle can induce anticancer activity. GP&#x02010;2250 impairs the energy metabolism by directly targeting the initial steps of glycolysis.</p></div><div id="jcmm17825-sec-0026" class="sec"><h3 id="jcmm17825-sec-0026title">4.2. Activation of <span style="fixed-case">AMPK</span>
</h3><p class="p p-first-last">The impairment of energy metabolism by GP&#x02010;2250 was most clearly apparent by the decrease of ATP (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0001" rid-ob="ob-jcmm17825-fig-0001" co-legend-rid="lgnd_jcmm17825-fig-0001"><span>1B,C</span></a>), which represents a threat to survival of the tumour cells. As a countermeasure to preserve ATP, the energy&#x02010;deficit sensor AMPK was activated as shown by the time&#x02010;dependent phosphorylation of the AMPK alpha subunit at threonine 172 in Panc Tul cells (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><span>5A</span></a>) and the dose dependency of the phosphorylation of AMPK in BxPC3 cells (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><span>5B</span></a>). AMPK activation is known to inhibit major downstream ATP&#x02010;consuming biosynthetic pathways required for cell growth and proliferation, including the synthesis of proteins, fatty acids, cholesterol, nucleotides, ribosomal RNA and glycogen.<a href="#jcmm17825-bib-0011" rid="jcmm17825-bib-0011" class=" bibr popnode">
<sup>11</sup>
</a>, <a href="#jcmm17825-bib-0012" rid="jcmm17825-bib-0012" class=" bibr popnode">
<sup>12</sup>
</a> Due to this austerity programme, AMPK activation suppresses tumour growth.<a href="#jcmm17825-bib-0010" rid="jcmm17825-bib-0010" class=" bibr popnode">
<sup>10</sup>
</a> The activation of AMPK is therefore a hallmark of the anticancer activity of GP&#x02010;2250.</p></div><div id="jcmm17825-sec-0027" class="sec"><h3 id="jcmm17825-sec-0027title">4.3. Inhibition of ACC</h3><p class="p p-first-last">AMPK inhibits lipogenic transcriptional programmes including the synthesis of fatty acids. This is in keeping with the phosphorylation of ACC&#x02010;1 in the presence of GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>), pointing to a potential deficit of fatty acid synthesis in Panc Tul and BxPC3 cells. The power of ACC inhibition in suppressing the growth of cancers is underlined by the finding that drug&#x02010;induced ACC phosphorylation or a specific ACC inhibitor was effective in suppressing hepatocellular carcinoma and pancreatic cancer.<a href="#jcmm17825-bib-0039" rid="jcmm17825-bib-0039" class=" bibr popnode">
<sup>39</sup>
</a>, <a href="#jcmm17825-bib-0040" rid="jcmm17825-bib-0040" class=" bibr popnode">
<sup>40</sup>
</a> Thus, the cytotoxicity of GP&#x02010;2250 may be attributed, at least in part, to a lack of fatty acid synthesis. The ability of supplementary OAA to rescue Panc Tul and BxPC3 cells from GP&#x02010;2250&#x02010;induced cytotoxicity (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003" co-legend-rid="lgnd_jcmm17825-fig-0003"><span>3A,B</span></a>) might be attributed, at least in part, to a possible restoration of fatty acid synthesis. An excess of OAA is likely to override the ACC inhibition by increasing the transport capacity to provide mitochondrial Acetyl&#x02010;CoA as substrate for the cytosolic ACC.</p></div><div id="jcmm17825-sec-0028" class="sec"><h3 id="jcmm17825-sec-0028title">4.4. Inhibition of <span style="fixed-case">RAPTOR</span>/<span style="fixed-case">mTOR</span>
</h3><p class="p p-first-last">AMPK regulates protein synthesis in large part by inhibition of the mTORC1 complex, a key driver of tumour growth.<a href="#jcmm17825-bib-0024" rid="jcmm17825-bib-0024" class=" bibr popnode">
<sup>24</sup>
</a>, <a href="#jcmm17825-bib-0041" rid="jcmm17825-bib-0041" class=" bibr popnode">
<sup>41</sup>
</a> The time&#x02010;dependent increase of RAPTOR phosphorylation at Ser792 by GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>), suggests that GP&#x02010;2250 is able to inhibit protein synthesis. There are reciprocal interactions between mTOR and Akt. The protein kinase Akt also drives tumour growth and proliferation. At high concentrations of GP&#x02010;2250, the protein levels of both mTOR and Akt were reduced, supporting the view that GP&#x02010;2250 inhibits protein synthesis (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). Besides inhibiting the activity of mTOR through RAPTOR phosphorylation, AMPK can also limit protein synthesis indirectly via TSC2 and directly by blocking RNA synthesis and protein elongation.<a href="#jcmm17825-bib-0011" rid="jcmm17825-bib-0011" class=" bibr popnode">
<sup>11</sup>
</a>, <a href="#jcmm17825-bib-0012" rid="jcmm17825-bib-0012" class=" bibr popnode">
<sup>12</sup>
</a>
</p></div><div id="jcmm17825-sec-0029" class="sec"><h3 id="jcmm17825-sec-0029title">4.5. A lack of nucleotides?</h3><p class="p p-first">As part of the downstream events of AMPK activation, the synthesis of nucleotides can be switched off by inhibition of PRPP (phosphoribosyl&#x02010;1&#x02010;pyrophosphate)&#x02010;synthase.<a href="#jcmm17825-bib-0011" rid="jcmm17825-bib-0011" class=" bibr popnode">
<sup>11</sup>
</a> Although not tested experimentally, an inhibition of nucleotide synthesis by GP&#x02010;2250 would be in keeping with the rescue experiment performed with OAA (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0003" rid-ob="ob-jcmm17825-fig-0003" co-legend-rid="lgnd_jcmm17825-fig-0003"><span>3A,B</span></a>). The synthesis of both pyrimidine&#x02010; and purine&#x02010;nucleotides requires aspartate.<a href="#jcmm17825-bib-0005" rid="jcmm17825-bib-0005" class=" bibr popnode">
<sup>5</sup>
</a>, <a href="#jcmm17825-bib-0007" rid="jcmm17825-bib-0007" class=" bibr popnode">
<sup>7</sup>
</a> As a precursor to aspartate, supplementary OAA may be able to restore the synthesis of nucleotides by replenishing aspartate and override PRPP inhibition. As nucleotides are essential building blocks for the formation of RNA and DNA, it cannot be excluded that impaired DNA and RNA synthesis is part of the cytotoxic effects of GP&#x02010;2250.</p><p class="p p-last">A deficiency in nucleotide synthesis would be expected to also reduce the level of nicotinamide adenine dinucleotide (NAD+). Among other functions, NAD serves as a substrate for the enzyme PARP [poly (ADP&#x02010;ribose) polymerase], which is required for single strand homologous recombination repair. As PARP inhibitors are used for the treatment of ovarian and other cancers, it is of interest that GP&#x02010;2250 might act as an indirect, metabolic PARP inhibitor by limiting the availability of the substrate NAD+.</p></div><div id="jcmm17825-sec-0030" class="sec sec-last"><h3 id="jcmm17825-sec-0030title">4.6. Inhibition of the <span style="fixed-case">NF&#x02010;&#x003ba;B</span> pathway</h3><p class="p p-first">NF&#x02010;&#x003ba;B ensures survival of the tumour cell in several ways. It enhances cell cycle progression by upregulating cyclin D1, prevents apoptosis by upregulating the anti&#x02010;apoptotic protein Bcl2 and protects cells from toxic ROS levels by upregulating antioxidant enzymes such as SOD1 and HMOX1.<a href="#jcmm17825-bib-0042" rid="jcmm17825-bib-0042" class=" bibr popnode">
<sup>42</sup>
</a> The cancer drugs tacrolimus and bortezomib act, at least in part, by suppressing NF&#x02010;&#x003ba;B.<a href="#jcmm17825-bib-0043" rid="jcmm17825-bib-0043" class=" bibr popnode">
<sup>43</sup>
</a>, <a href="#jcmm17825-bib-0044" rid="jcmm17825-bib-0044" class=" bibr popnode">
<sup>44</sup>
</a> GP&#x02010;2250 was found to act as NF&#x02010;kB inhibitor based on its inhibition of p65/DNA binding in nuclear lysates. This was apparent not only in nuclear lysates prepared from cells treated with GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004" co-legend-rid="lgnd_jcmm17825-fig-0004"><span>4C,D</span></a>), but also in nuclear lysates prepared from untreated cells with subsequent incubation of the lysate with GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0004" rid-ob="ob-jcmm17825-fig-0004" co-legend-rid="lgnd_jcmm17825-fig-0004"><span>4E,F</span></a>). It is of note, that the dose dependency for p65/DNA binding in treated lysates was comparable to that from the lysates of treated cells. This finding suggests that GP&#x02010;2250 is likely to directly interfere with the binding of p65 to DNA and not with an upstream event.</p><p>A reduction of the transcriptional activity of NF&#x02010;&#x003ba;B was apparent in both Panc Tul and BxPC3 cell lines by the change in expression of cyclin D1 and Bcl2. This is testimony to the functional relevance of NF&#x02010;kB inhibition by GP&#x02010;2250. The expression of cyclin D1, the driver of cell cycle progression, was reduced by GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0005" rid-ob="ob-jcmm17825-fig-0005" co-legend-rid="lgnd_jcmm17825-fig-0005"><span>5</span></a>). This finding is in line with the previously shown reduction of the rate of cell proliferation by GP&#x02010;2250.<a href="#jcmm17825-bib-0001" rid="jcmm17825-bib-0001" class=" bibr popnode">
<sup>1</sup>
</a> The expression of the anti&#x02010;apoptotic protein Bcl2 was likewise reduced by GP&#x02010;2250 (Figure&#x000a0;<a href="/pmc/articles/PMC10339077/figure/jcmm17825-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="jcmm17825-fig-0006" rid-ob="ob-jcmm17825-fig-0006" co-legend-rid="lgnd_jcmm17825-fig-0006"><span>6</span></a>). Thus, by inhibiting NF&#x02010;&#x003ba;B, GP&#x02010;2250 is able to disrupt tumour progression in a two&#x02010;pronged manner, by reducing the rate of cell proliferation and promoting apoptosis.</p><p class="p p-last">Several limitations of this study must be taken into account. The present study is exclusively an in vitro analysis using pancreatic cancer cell line models. The impact of GP&#x02010;2250 on growth control via lipid and protein synthesis requires further study. Whether the present findings can be confirmed in an analysis of pancreatic cancer tissue in mouse PDX models remains to be seen. Further studies are also required to test whether the mechanism of action described here extends to other types of tumours.</p></div></div><div id="jcmm17825-sec-0031" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0031title">5. CONCLUSION</h2><p class="p p-first-last">The anticancer agent GP&#x02010;2250, presently in clinical development, acts by disrupting the energy metabolism through direct inhibition of HK2, GAPDH and an impact on the TCA cycle. This view is supported by the ability of supplementary OAA and PYR to protect the tumour cells to a large extent from drug&#x02010;induced cytotoxicity. Activation of the energy&#x02010;deficit sensor AMPK is attributed to the deficit of ATP. Its downstream events include the inhibition of ACC, the rate&#x02010;limiting enzyme of fatty acid synthesis and inhibition of the Raptor/mTor complex, both of which limit the synthesis of essential cell components. In addition to metabolic deficits, the transcriptional activity of the tumour promoter NF&#x02010;&#x003ba;B is inhibited by GP&#x02010;2250. The downregulation of cyclin D1 and the anti&#x02010;apoptotic Bcl2 is in line with a reduction of the rate of tumour cell proliferation and induction of apoptosis, respectively. The upregulation of p53 concomitant with the rise of ROS further contributes to cytotoxicity. These metabolic and transcriptional findings provide a molecular basis for the ability of GP&#x02010;2250 to reduce tumour cell proliferation and induce apoptotic cell death as shown here for pancreatic cancer cells. The effectiveness of GP&#x02010;2250 in patient&#x02010;derived xenograft mouse models and its role in combination with approved anticancer drugs, such as gemcitabine, is under investigation.</p></div><div id="jcmm17825-sec-0036" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0036title">AUTHOR CONTRIBUTIONS</h2><p class="p p-first-last">
<strong>Britta Majchrzak&#x02010;Stiller:</strong> Conceptualization (equal); data curation (equal); formal analysis (equal); methodology (equal); visualization (equal); writing &#x02013; original draft (equal). <strong>Marie Buchholz:</strong> Conceptualization (equal); data curation (equal); formal analysis (equal); methodology (equal); visualization (equal); writing &#x02013; original draft (equal). <strong>Ilka Peters:</strong> Investigation (equal); validation (equal); writing &#x02013; review and editing (equal). <strong>Daniel Waschestjuk:</strong> Investigation (equal); validation (equal). <strong>Johanna Strotmann:</strong> Investigation (equal); validation (equal). <strong>Philipp H&#x000f6;hn:</strong> Conceptualization (equal); funding acquisition (equal); writing &#x02013; original draft (equal). <strong>Stephan Hahn:</strong> Investigation (equal); resources (equal); writing &#x02013; review and editing (equal). <strong>Chris Braumann:</strong> Conceptualization (equal); funding acquisition (equal); supervision (equal); writing &#x02013; review and editing (equal). <strong>Waldemar Uhl:</strong> Conceptualization (equal); funding acquisition (equal); resources (equal). <strong>Thomas M&#x000fc;ller:</strong> Resources (equal); writing &#x02013; review and editing (equal). <strong>Hanns M&#x000f6;hler:</strong> Conceptualization (equal); project administration (equal); supervision (equal); writing &#x02013; original draft (equal); writing &#x02013; review and editing (equal).</p></div><div id="jcmm17825-sec-0033" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0033title">CONFLICT OF INTEREST STATEMENT</h2><p class="p p-first-last">BM&#x02010;S, MB, IP, DW, JS, PH, WU are employees of Department of General and Visceral Surgery, St. Josef&#x02010;Hospital, Germany, which received research funding from Geistlich Pharma AG to conduct the study.HM received consultancy fees from Geistlich Pharma AG. TM is employed by Geistlich Pharma AG, Wolhusen, Switzerland (Geistlich). Beyond the contribution of one author (who provided chemical expertise of the analysed agent) Geistlich had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. All other authors declare no competing interests.</p></div><div id="jcmm17825-sec-0032" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0032title">ACKNOWLEDGEMENTS</h2><div class="sec"><p>The substance GP&#x02010;2250 was kindly provided by Geistlich Pharma AG (Geistlich), Wolhusen, Switzerland. The consumables used in this work were partially funded by Geistlich Pharma AG, Wolhusen, Switzerland and partly funded by the Department of General and Visceral Surgery of the St. Josef&#x02010;Hospital. Funding for this research study was provided by Geistlich Pharma AG. All listed authors meet the criteria for authorship set forth by the International Committee of Medical Journal Editors. Open Access funding enabled and organized by Projekt DEAL.</p></div></div><div id="notes-a.j.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.j.ctitle">Notes</h2><p>
<span class="mixed-citation" id="JCMM17825-cit-2001">
Majchrzak&#x02010;Stiller B, Buchholz M, Peters I, et al. <span class="ref-title">
GP&#x02010;2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP&#x02010;Kinase and impairs the NF&#x02010;kB pathway in pancreatic cancer cells</span>. <span class="ref-journal">J Cell Mol Med</span>. 2023;<span class="ref-vol">27</span>:2082&#x02010;2092. doi: 10.1111/jcmm.17825
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10339077/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37390227" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fjcmm.17825" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Mol+Med&amp;title=&#10;GP&#x02010;2250,+a+novel+anticancer+agent,+inhibits+the+energy+metabolism,+activates+AMP&#x02010;Kinase+and+impairs+the+NF&#x02010;kB+pathway+in+pancreatic+cancer+cells&amp;volume=27&amp;publication_year=2023&amp;pages=2082-2092&amp;pmid=37390227&amp;doi=10.1111/jcmm.17825&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span>
</p></div><div id="jcmm17825-sec-0035" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="jcmm17825-sec-0035title">DATA AVAILABILITY STATEMENT</h2><!--/article/back/sec/--><p class="p p-first-last">The data presented in this study are available on request from the corresponding author.</p></div><div id="jcmm17825-bibl-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="jcmm17825-bibl-0001title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0001">1. <span class="mixed-citation" id="jcmm17825-cit-0001">
Buchholz M, Majchrzak&#x02010;Stiller B, Hahn S, et al. <span class="ref-title">Innovative substance 2250 as a highly promising anti&#x02010;neoplastic agent in malignant pancreatic carcinoma &#x02013; in vitro and in vivo</span>. <span class="ref-journal">BMC Cancer</span>. 2017;<span class="ref-vol">17</span>:216. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5366103/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28340556" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;title=Innovative+substance+2250+as+a+highly+promising+anti&#x02010;neoplastic+agent+in+malignant+pancreatic+carcinoma+&#x02013;+in+vitro+and+in+vivo&amp;volume=17&amp;publication_year=2017&amp;pages=216&amp;pmid=28340556&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0002">2. <span class="mixed-citation" id="jcmm17825-cit-0002">
Buchholz M, Strotmann J, Majchrzak&#x02010;Stiller B, et al. <span class="ref-title">New therapy options for neuroendocrine carcinoma of the pancreas&#x02010;the emergent substance GP&#x02010;2250 and gemcitabine prove to Be highly effective without the development of secondary resistances in vitro and in vivo</span>. <span class="ref-journal">Cancer</span>. 2022;<span class="ref-vol">14</span>:2685. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9179328/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35681665" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=New+therapy+options+for+neuroendocrine+carcinoma+of+the+pancreas&#x02010;the+emergent+substance+GP&#x02010;2250+and+gemcitabine+prove+to+Be+highly+effective+without+the+development+of+secondary+resistances+in+vitro+and+in+vivo&amp;volume=14&amp;publication_year=2022&amp;pages=2685&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0003">3. <span class="mixed-citation" id="jcmm17825-cit-0003">
Geistlich Pharma AG, Translational Drug Development
. <span class="ref-title">A phase 1/2 trial of GP&#x02010;2250 in combination with gemcitabine in pancreatic adenocarcinoma after FOLFIRINOX Chemotherapy: NCT03854110, GP&#x02010;2250&#x02010;1001</span>. Available at: https://clinicaltrials.gov/ct2/show/<a id="__tag_1137998990" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT03854110" ref="reftype=extlink-clinical-trial&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT03854110","term_id":"NCT03854110"}}</span>NCT03854110</a>; 2021 [Accessed 12.11.2021].</span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0004">4. <span class="mixed-citation" id="jcmm17825-cit-0004">
Baron C, Buchholz M, Majchrzak&#x02010;Stiller B, et al. <span class="ref-title">Substance GP&#x02010;2250 as a new therapeutic agent for malignant peritoneal mesothelioma&#x02010;a 3&#x02010;D In vitro study</span>. <span class="ref-journal">Int J Mol Sci</span>. 2022;<span class="ref-vol">23</span>:7293. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9267014/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35806313" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Sci&amp;title=Substance+GP&#x02010;2250+as+a+new+therapeutic+agent+for+malignant+peritoneal+mesothelioma&#x02010;a+3&#x02010;D+In+vitro+study&amp;volume=23&amp;publication_year=2022&amp;pages=7293&amp;pmid=35806313&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0005">5. <span class="mixed-citation" id="jcmm17825-cit-0005">
DeBerardinis RJ, Chandel NS. <span class="ref-title">Fundamentals of cancer metabolism</span>. <span class="ref-journal">Sci Adv</span>. 2016;<span class="ref-vol">2</span>:e1600200. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4928883/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27386546" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Adv&amp;title=Fundamentals+of+cancer+metabolism&amp;volume=2&amp;publication_year=2016&amp;pages=e1600200&amp;pmid=27386546&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0006">6. <span class="mixed-citation" id="jcmm17825-cit-0006">
Locasale JW, Cantley LC. <span class="ref-title">Metabolic flux and the regulation of mammalian cell growth</span>. <span class="ref-journal">Cell Metab</span>. 2011;<span class="ref-vol">14</span>:443&#x02010;451. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3196640/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21982705" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Metabolic+flux+and+the+regulation+of+mammalian+cell+growth&amp;volume=14&amp;publication_year=2011&amp;pages=443-451&amp;pmid=21982705&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0007">7. <span class="mixed-citation" id="jcmm17825-cit-0007">
Vander Heiden MG, Cantley LC, Thompson CB. <span class="ref-title">Understanding the Warburg effect: the metabolic requirements of cell proliferation</span>. <span class="ref-journal">Science (New York, N.Y.)</span>. 2009;<span class="ref-vol">324</span>:1029&#x02010;1033. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2849637/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19460998" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science+(New+York,+N.Y.)&amp;title=Understanding+the+Warburg+effect:+the+metabolic+requirements+of+cell+proliferation&amp;volume=324&amp;publication_year=2009&amp;pages=1029-1033&amp;pmid=19460998&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0008">8. <span class="mixed-citation" id="jcmm17825-cit-0008">
Ciscato F, Ferrone L, Masgras I, Laquatra C, Rasola A. <span class="ref-title">Hexokinase 2 in cancer: a prima Donna playing multiple characters</span>. <span class="ref-journal">Int J Mol Sci</span>. 2021;<span class="ref-vol">22</span>:4716. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8125560/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33946854" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Sci&amp;title=Hexokinase+2+in+cancer:+a+prima+Donna+playing+multiple+characters&amp;volume=22&amp;publication_year=2021&amp;pages=4716&amp;pmid=33946854&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0009">9. <span class="mixed-citation" id="jcmm17825-cit-0009">
Liberti MV, Dai Z, Wardell SE, et al. <span class="ref-title">A predictive model for selective targeting of the Warburg effect through GAPDH inhibition with a natural product</span>. <span class="ref-journal">Cell Metab</span>. 2017;<span class="ref-vol">26</span>:648&#x02010;659.e8. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5629112/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28918937" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=A+predictive+model+for+selective+targeting+of+the+Warburg+effect+through+GAPDH+inhibition+with+a+natural+product&amp;volume=26&amp;publication_year=2017&amp;pages=648-659.e8&amp;pmid=28918937&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0010">10. <span class="mixed-citation" id="jcmm17825-cit-0010">
Faubert B, Boily G, Izreig S, et al. <span class="ref-title">AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo</span>. <span class="ref-journal">Cell Metab</span>. 2013;<span class="ref-vol">17</span>:113&#x02010;124. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3545102/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23274086" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=AMPK+is+a+negative+regulator+of+the+Warburg+effect+and+suppresses+tumor+growth+in+vivo&amp;volume=17&amp;publication_year=2013&amp;pages=113-124&amp;pmid=23274086&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0011">11. <span class="mixed-citation" id="jcmm17825-cit-0011">
Gonz&#x000e1;lez A, Hall MN, Lin S&#x02010;C, Hardie DG. <span class="ref-title">AMPK and TOR: the yin and Yang of cellular nutrient sensing and growth control</span>. <span class="ref-journal">Cell Metab</span>. 2020;<span class="ref-vol">31</span>:472&#x02010;492. [<a href="https://pubmed.ncbi.nlm.nih.gov/32130880" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=AMPK+and+TOR:+the+yin+and+Yang+of+cellular+nutrient+sensing+and+growth+control&amp;volume=31&amp;publication_year=2020&amp;pages=472-492&amp;pmid=32130880&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0012">12. <span class="mixed-citation" id="jcmm17825-cit-0012">
Garcia D, Shaw RJ. <span class="ref-title">AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance</span>. <span class="ref-journal">Mol Cell</span>. 2017;<span class="ref-vol">66</span>:789&#x02010;800. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5553560/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28622524" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=AMPK:+mechanisms+of+cellular+energy+sensing+and+restoration+of+metabolic+balance&amp;volume=66&amp;publication_year=2017&amp;pages=789-800&amp;pmid=28622524&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0013">13. <span class="mixed-citation" id="jcmm17825-cit-0013">
Salminen A, Hyttinen JMT, Kaarniranta K. <span class="ref-title">AMP&#x02010;activated protein kinase inhibits NF&#x02010;&#x003ba;B signaling and inflammation: impact on healthspan and lifespan</span>. <span class="ref-journal">J Mol Med (Berl)</span>. 2011;<span class="ref-vol">89</span>:667&#x02010;676. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3111671/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21431325" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Med+(Berl)&amp;title=AMP&#x02010;activated+protein+kinase+inhibits+NF&#x02010;&#x003ba;B+signaling+and+inflammation:+impact+on+healthspan+and+lifespan&amp;volume=89&amp;publication_year=2011&amp;pages=667-676&amp;pmid=21431325&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0014">14. <span class="mixed-citation" id="jcmm17825-cit-0014">
Tan MH, Nowak NJ, Loor R, et al. <span class="ref-title">Characterization of a new primary human pancreatic tumor line</span>. <span class="ref-journal">Cancer Invest</span>. 1986;<span class="ref-vol">4</span>:15&#x02010;23. [<a href="https://pubmed.ncbi.nlm.nih.gov/3754176" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Invest&amp;title=Characterization+of+a+new+primary+human+pancreatic+tumor+line&amp;volume=4&amp;publication_year=1986&amp;pages=15-23&amp;pmid=3754176&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0015">15. <span class="mixed-citation" id="jcmm17825-cit-0015">
Kalthoff H, Schmiegel W, Roeder C, et al. <span class="ref-title">p53 and K&#x02010;RAS alterations in pancreatic epithelial cell lesions</span>. <span class="ref-journal">Oncogene</span>. 1993;<span class="ref-vol">8</span>:289&#x02010;298. [<a href="https://pubmed.ncbi.nlm.nih.gov/8426738" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=p53+and+K&#x02010;RAS+alterations+in+pancreatic+epithelial+cell+lesions&amp;volume=8&amp;publication_year=1993&amp;pages=289-298&amp;pmid=8426738&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0016">16. <span class="mixed-citation" id="jcmm17825-cit-0016">
Moritz CP. <span class="ref-title">40&#x02009;years Western blotting: a scientific birthday toast</span>. <span class="ref-journal">J Proteomics</span>. 2020;<span class="ref-vol">212</span>:103575. [<a href="https://pubmed.ncbi.nlm.nih.gov/31706026" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Proteomics&amp;title=40&#x02009;years+Western+blotting:+a+scientific+birthday+toast&amp;volume=212&amp;publication_year=2020&amp;pages=103575&amp;pmid=31706026&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0017">17. <span class="mixed-citation" id="jcmm17825-cit-0017">
Anderson M, Marayati R, Moffitt R, Yeh JJ. <span class="ref-title">Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer</span>. <span class="ref-journal">Oncotarget</span>. 2017;<span class="ref-vol">8</span>:56081&#x02010;56094. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5593546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28915575" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Hexokinase+2+promotes+tumor+growth+and+metastasis+by+regulating+lactate+production+in+pancreatic+cancer&amp;volume=8&amp;publication_year=2017&amp;pages=56081-56094&amp;pmid=28915575&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0018">18. <span class="mixed-citation" id="jcmm17825-cit-0018">
Kornberg MD, Bhargava P, Kim PM, et al. <span class="ref-title">Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity</span>. <span class="ref-journal">Science (New York, N.Y.)</span>. 2018;<span class="ref-vol">360</span>:449&#x02010;453. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5924419/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29599194" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science+(New+York,+N.Y.)&amp;title=Dimethyl+fumarate+targets+GAPDH+and+aerobic+glycolysis+to+modulate+immunity&amp;volume=360&amp;publication_year=2018&amp;pages=449-453&amp;pmid=29599194&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0019">19. <span class="mixed-citation" id="jcmm17825-cit-0019">
Liu X, Liu X, Bai J, et al. <span class="ref-title">Glyceraldehyde&#x02010;3&#x02010;phosphate dehydrogenase restricted in cytoplasmic location by viral GP5 facilitates porcine reproductive and respiratory syndrome virus replication via its glycolytic activity</span>. <span class="ref-journal">J Virol</span>. 2021;<span class="ref-vol">95</span>:e0021021. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8387053/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34160254" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Glyceraldehyde&#x02010;3&#x02010;phosphate+dehydrogenase+restricted+in+cytoplasmic+location+by+viral+GP5+facilitates+porcine+reproductive+and+respiratory+syndrome+virus+replication+via+its+glycolytic+activity&amp;volume=95&amp;publication_year=2021&amp;pages=e0021021&amp;pmid=34160254&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0020">20. <span class="mixed-citation" id="jcmm17825-cit-0020">
Tretter L, Adam&#x02010;Vizi V. <span class="ref-title">Alpha&#x02010;ketoglutarate dehydrogenase: a target and generator of oxidative stress</span>. <span class="ref-journal">Philos Trans R Soc Lond B Biol Sci</span>. 2005;<span class="ref-vol">360</span>:2335&#x02010;2345. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1569585/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16321804" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Philos+Trans+R+Soc+Lond+B+Biol+Sci&amp;title=Alpha&#x02010;ketoglutarate+dehydrogenase:+a+target+and+generator+of+oxidative+stress&amp;volume=360&amp;publication_year=2005&amp;pages=2335-2345&amp;pmid=16321804&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0021">21. <span class="mixed-citation" id="jcmm17825-cit-0021">
Joaqu&#x000ed;n&#x02010;Ovalle FM, Guihurt G, Barcelo&#x02010;Bovea V, et al. <span class="ref-title">Oxidative stress&#x02010; and autophagy&#x02010;inducing effects of PSI&#x02010;LHCI from Botryococcus braunii in breast cancer cells</span>. <span class="ref-journal">Biotech (Basel)</span>. 2022;<span class="ref-vol">11</span>:9. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9264392/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35822782" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biotech+(Basel)&amp;title=Oxidative+stress&#x02010;+and+autophagy&#x02010;inducing+effects+of+PSI&#x02010;LHCI+from+Botryococcus+braunii+in+breast+cancer+cells&amp;volume=11&amp;publication_year=2022&amp;pages=9&amp;pmid=35822782&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0022">22. <span class="mixed-citation" id="jcmm17825-cit-0022">
Mantsounga CS, Lee C, Neverson J, et al. <span class="ref-title">Macrophage IL&#x02010;1&#x003b2; promotes arteriogenesis by autocrine STAT3&#x02010; and NF&#x02010;&#x003ba;B&#x02010;mediated transcription of pro&#x02010;angiogenic VEGF&#x02010;A</span>. <span class="ref-journal">Cell Rep</span>. 2022;<span class="ref-vol">38</span>:110309. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8865931/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35108537" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep&amp;title=Macrophage+IL&#x02010;1&#x003b2;+promotes+arteriogenesis+by+autocrine+STAT3&#x02010;+and+NF&#x02010;&#x003ba;B&#x02010;mediated+transcription+of+pro&#x02010;angiogenic+VEGF&#x02010;A&amp;volume=38&amp;publication_year=2022&amp;pages=110309&amp;pmid=35108537&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0023">23. <span class="mixed-citation" id="jcmm17825-cit-0023">
Saxton RA, Sabatini DM. <span class="ref-title">mTOR signaling in growth, metabolism, and disease</span>. <span class="ref-journal">Cell</span>. 2017;<span class="ref-vol">168</span>:960&#x02010;976. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5394987/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28283069" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=mTOR+signaling+in+growth,+metabolism,+and+disease&amp;volume=168&amp;publication_year=2017&amp;pages=960-976&amp;pmid=28283069&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0024">24. <span class="mixed-citation" id="jcmm17825-cit-0024">
P&#x000f3;pulo H, Lopes JM, Soares P. <span class="ref-title">The mTOR signalling pathway in human cancer</span>. <span class="ref-journal">Int J Mol Sci</span>. 2012;<span class="ref-vol">13</span>:1886&#x02010;1918. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3291999/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22408430" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Sci&amp;title=The+mTOR+signalling+pathway+in+human+cancer&amp;volume=13&amp;publication_year=2012&amp;pages=1886-1918&amp;pmid=22408430&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0025">25. <span class="mixed-citation" id="jcmm17825-cit-0025">
Mihaylova MM, Shaw RJ. <span class="ref-title">The AMPK signalling pathway coordinates cell growth, autophagy and metabolism</span>. <span class="ref-journal">Nat Cell Biol</span>. 2011;<span class="ref-vol">13</span>:1016&#x02010;1023. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3249400/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21892142" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Cell+Biol&amp;title=The+AMPK+signalling+pathway+coordinates+cell+growth,+autophagy+and+metabolism&amp;volume=13&amp;publication_year=2011&amp;pages=1016-1023&amp;pmid=21892142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0026">26. <span class="mixed-citation" id="jcmm17825-cit-0026">
Gwinn DM, Shackelford DB, Egan DF, et al. <span class="ref-title">AMPK phosphorylation of raptor mediates a metabolic checkpoint</span>. <span class="ref-journal">Mol Cell</span>. 2008;<span class="ref-vol">30</span>:214&#x02010;226. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2674027/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18439900" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=AMPK+phosphorylation+of+raptor+mediates+a+metabolic+checkpoint&amp;volume=30&amp;publication_year=2008&amp;pages=214-226&amp;pmid=18439900&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0027">27. <span class="mixed-citation" id="jcmm17825-cit-0027">
Thoreen CC, Sabatini DM. <span class="ref-title">AMPK and p53 help cells through lean times</span>. <span class="ref-journal">Cell Metab</span>. 2005;<span class="ref-vol">1</span>:287&#x02010;288. [<a href="https://pubmed.ncbi.nlm.nih.gov/16054073" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=AMPK+and+p53+help+cells+through+lean+times&amp;volume=1&amp;publication_year=2005&amp;pages=287-288&amp;pmid=16054073&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0028">28. <span class="mixed-citation" id="jcmm17825-cit-0028">
Yogosawa S, Yoshida K. <span class="ref-title">Tumor suppressive role for kinases phosphorylating p53 in DNA damage&#x02010;induced apoptosis</span>. <span class="ref-journal">Cancer Sci</span>. 2018;<span class="ref-vol">109</span>:3376&#x02010;3382. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6215896/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30191640" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Sci&amp;title=Tumor+suppressive+role+for+kinases+phosphorylating+p53+in+DNA+damage&#x02010;induced+apoptosis&amp;volume=109&amp;publication_year=2018&amp;pages=3376-3382&amp;pmid=30191640&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0029">29. <span class="mixed-citation" id="jcmm17825-cit-0029">
Stine ZE, Schug ZT, Salvino JM, Dang CV. <span class="ref-title">Targeting cancer metabolism in the era of precision oncology</span>. <span class="ref-journal">Nat Rev Drug Discov</span>. 2022;<span class="ref-vol">21</span>:141&#x02010;162. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8641543/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34862480" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Drug+Discov&amp;title=Targeting+cancer+metabolism+in+the+era+of+precision+oncology&amp;volume=21&amp;publication_year=2022&amp;pages=141-162&amp;pmid=34862480&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0030">30. <span class="mixed-citation" id="jcmm17825-cit-0030">
Pavlova NN, Thompson CB. <span class="ref-title">The emerging hallmarks of cancer metabolism</span>. <span class="ref-journal">Cell Metab</span>. 2016;<span class="ref-vol">23</span>:27&#x02010;47. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4715268/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26771115" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=The+emerging+hallmarks+of+cancer+metabolism&amp;volume=23&amp;publication_year=2016&amp;pages=27-47&amp;pmid=26771115&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0031">31. <span class="mixed-citation" id="jcmm17825-cit-0031">
Saidu B, Edward N, Bretagne M, et al. <span class="ref-title">Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non&#x02010;tumorigenic cells</span>. <span class="ref-journal">Oncotarget</span>. 2018;<span class="ref-vol">9</span>:9088&#x02010;9099. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5823659/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29507676" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Dimethyl+fumarate+is+highly+cytotoxic+in+KRAS+mutated+cancer+cells+but+spares+non&#x02010;tumorigenic+cells&amp;volume=9&amp;publication_year=2018&amp;pages=9088-9099&amp;pmid=29507676&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0032">32. <span class="mixed-citation" id="jcmm17825-cit-0032">
Kaluzki I, Hailemariam&#x02010;Jahn T, Doll M, et al. <span class="ref-title">Dimethylfumarate inhibits colorectal carcinoma cell proliferation: evidence for cell cycle arrest, apoptosis and autophagy</span>. <span class="ref-journal">Cells</span>. 2019;<span class="ref-vol">8</span>:1329. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6912700/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31661890" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Dimethylfumarate+inhibits+colorectal+carcinoma+cell+proliferation:+evidence+for+cell+cycle+arrest,+apoptosis+and+autophagy&amp;volume=8&amp;publication_year=2019&amp;pages=1329&amp;pmid=31661890&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0033">33. <span class="mixed-citation" id="jcmm17825-cit-0033">
Kastrati I, Siklos MI, Calderon&#x02010;Gierszal EL, et al. <span class="ref-title">Dimethyl fumarate inhibits the nuclear factor &#x003ba;B pathway in breast cancer cells by covalent modification of p65 protein</span>. <span class="ref-journal">J Biol Chem</span>. 2016;<span class="ref-vol">291</span>:3639&#x02010;3647. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4751401/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26683377" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Dimethyl+fumarate+inhibits+the+nuclear+factor+&#x003ba;B+pathway+in+breast+cancer+cells+by+covalent+modification+of+p65+protein&amp;volume=291&amp;publication_year=2016&amp;pages=3639-3647&amp;pmid=26683377&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0034">34. <span class="mixed-citation" id="jcmm17825-cit-0034">
Takeda T, Tsubaki M, Asano R, et al. <span class="ref-title">Dimethyl fumarate suppresses metastasis and growth of melanoma cells by inhibiting the nuclear translocation of NF&#x02010;&#x003ba;B</span>. <span class="ref-journal">J Dermatol Sci</span>. 2020;<span class="ref-vol">99</span>:168&#x02010;176. [<a href="https://pubmed.ncbi.nlm.nih.gov/32693971" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Dermatol+Sci&amp;title=Dimethyl+fumarate+suppresses+metastasis+and+growth+of+melanoma+cells+by+inhibiting+the+nuclear+translocation+of+NF&#x02010;&#x003ba;B&amp;volume=99&amp;publication_year=2020&amp;pages=168-176&amp;pmid=32693971&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0035">35. <span class="mixed-citation" id="jcmm17825-cit-0035">
Ganapathy&#x02010;Kanniappan S, Kunjithapatham R, Geschwind J&#x02010;F. <span class="ref-title">Glyceraldehyde&#x02010;3&#x02010;phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma</span>. <span class="ref-journal">Oncotarget</span>. 2012;<span class="ref-vol">3</span>:940&#x02010;953. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3660062/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22964488" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Glyceraldehyde&#x02010;3&#x02010;phosphate+dehydrogenase:+a+promising+target+for+molecular+therapy+in+hepatocellular+carcinoma&amp;volume=3&amp;publication_year=2012&amp;pages=940-953&amp;pmid=22964488&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0036">36. <span class="mixed-citation" id="jcmm17825-cit-0036">
Woolbright BL, Rajendran G, Harris RA, Taylor JA. <span class="ref-title">Metabolic flexibility in cancer: targeting the pyruvate dehydrogenase kinase:pyruvate dehydrogenase Axis</span>. <span class="ref-journal">Mol Cancer Ther</span>. 2019;<span class="ref-vol">18</span>:1673&#x02010;1681. [<a href="https://pubmed.ncbi.nlm.nih.gov/31511353" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Metabolic+flexibility+in+cancer:+targeting+the+pyruvate+dehydrogenase+kinase:pyruvate+dehydrogenase+Axis&amp;volume=18&amp;publication_year=2019&amp;pages=1673-1681&amp;pmid=31511353&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0037">37. <span class="mixed-citation" id="jcmm17825-cit-0037">
Stuart SD, Schauble A, Gupta S, et al. <span class="ref-title">A strategically designed small molecule attacks alpha&#x02010;ketoglutarate dehydrogenase in tumor cells through a redox process</span>. <span class="ref-journal">Cancer &#x00026; Metabolism</span>. 2014;<span class="ref-vol">2</span>:4. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4108059/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24612826" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+&#x00026;+Metabolism&amp;title=A+strategically+designed+small+molecule+attacks+alpha&#x02010;ketoglutarate+dehydrogenase+in+tumor+cells+through+a+redox+process&amp;volume=2&amp;publication_year=2014&amp;pages=4&amp;pmid=24612826&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0038">38. <span class="mixed-citation" id="jcmm17825-cit-0038">
Atlante S, Visintin A, Marini E, et al. <span class="ref-title">&#x003b1;&#x02010;Ketoglutarate dehydrogenase inhibition counteracts breast cancer&#x02010;associated lung metastasis</span>. <span class="ref-journal">Cell Death Dis</span>. 2018;<span class="ref-vol">9</span>:756. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6037705/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29988033" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis&amp;title=&#x003b1;&#x02010;Ketoglutarate+dehydrogenase+inhibition+counteracts+breast+cancer&#x02010;associated+lung+metastasis&amp;volume=9&amp;publication_year=2018&amp;pages=756&amp;pmid=29988033&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0039">39. <span class="mixed-citation" id="jcmm17825-cit-0039">
Lally JSV, Ghoshal S, DePeralta DK, et al. <span class="ref-title">Inhibition of acetyl&#x02010;CoA carboxylase by phosphorylation or the inhibitor ND&#x02010;654 suppresses lipogenesis and hepatocellular carcinoma</span>. <span class="ref-journal">Cell Metab</span>. 2019;<span class="ref-vol">29</span>:174&#x02010;182.e5. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6643297/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30244972" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Inhibition+of+acetyl&#x02010;CoA+carboxylase+by+phosphorylation+or+the+inhibitor+ND&#x02010;654+suppresses+lipogenesis+and+hepatocellular+carcinoma&amp;volume=29&amp;publication_year=2019&amp;pages=174-182.e5&amp;pmid=30244972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0040">40. <span class="mixed-citation" id="jcmm17825-cit-0040">
Gao L, Xu Z, Huang Z, et al. <span class="ref-title">CPI&#x02010;613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK&#x02010;ACC signaling</span>. <span class="ref-journal">Exp Clin Cancer Res</span>. 2020;<span class="ref-vol">39</span>:73. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7187515/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32345326" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Clin+Cancer+Res&amp;title=CPI&#x02010;613+rewires+lipid+metabolism+to+enhance+pancreatic+cancer+apoptosis+via+the+AMPK&#x02010;ACC+signaling&amp;volume=39&amp;publication_year=2020&amp;pages=73&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0041">41. <span class="mixed-citation" id="jcmm17825-cit-0041">
Dancey J. <span class="ref-title">mTOR signaling and drug development in cancer</span>. <span class="ref-journal">Nat Rev Clin Oncol</span>. 2010;<span class="ref-vol">7</span>:209&#x02010;219. [<a href="https://pubmed.ncbi.nlm.nih.gov/20234352" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Clin+Oncol&amp;title=mTOR+signaling+and+drug+development+in+cancer&amp;volume=7&amp;publication_year=2010&amp;pages=209-219&amp;pmid=20234352&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0042">42. <span class="mixed-citation" id="jcmm17825-cit-0042">
Karin M. <span class="ref-title">Nuclear factor&#x02010;kappaB in cancer development and progression</span>. <span class="ref-journal">Nature</span>. 2006;<span class="ref-vol">441</span>:431&#x02010;436. [<a href="https://pubmed.ncbi.nlm.nih.gov/16724054" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Nuclear+factor&#x02010;kappaB+in+cancer+development+and+progression&amp;volume=441&amp;publication_year=2006&amp;pages=431-436&amp;pmid=16724054&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0043">43. <span class="mixed-citation" id="jcmm17825-cit-0043">
Vafadari R, Kraaijeveld R, Weimar W, Baan CC. <span class="ref-title">Tacrolimus inhibits NF&#x02010;&#x003ba;B activation in peripheral human T cells</span>. <span class="ref-journal">PLoS One</span>. 2013;<span class="ref-vol">8</span>:e60784. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3613409/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23573283" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Tacrolimus+inhibits+NF&#x02010;&#x003ba;B+activation+in+peripheral+human+T+cells&amp;volume=8&amp;publication_year=2013&amp;pages=e60784&amp;pmid=23573283&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="jcmm17825-bib-0044">44. <span class="mixed-citation" id="jcmm17825-cit-0044">
Zavrski I, Jakob C, Kaiser M, Fleissner C, Heider U, Sezer O. <span class="ref-title">Molecular and clinical aspects of proteasome inhibition in the treatment of cancer</span>. <span class="ref-journal">Recent Results Cancer Res</span>. 2007;<span class="ref-vol">176</span>:165&#x02010;176. [<a href="https://pubmed.ncbi.nlm.nih.gov/17607924" ref="reftype=pubmed&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Recent+Results+Cancer+Res&amp;title=Molecular+and+clinical+aspects+of+proteasome+inhibition+in+the+treatment+of+cancer&amp;volume=176&amp;publication_year=2007&amp;pages=165-176&amp;pmid=17607924&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10339077&amp;issue-id=440620&amp;journal-id=2233&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Journal of Cellular and Molecular Medicine</span> are provided here courtesy of <strong>Blackwell Publishing</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10339077/pdf/JCMM-27-2082.pdf" class="int-view">PDF (3.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10339077/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10339077/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10339077" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10339077%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="VlxTsZpVC2YgOhuDmlygi1RnRky504Q7naVmsi8uOM9yzgrAtOyR5wdQrdd2cZWT">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10339077%2F&amp;text=%0AGP%020102250%2C%20a%20novel%20anticancer%20agent%2C%20inhibits%20the%20energy%20metabolism%2C%20activates%20AMP%02010Kinase%20and%20impairs%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10339077%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339077/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10339077/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37390227/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10339077/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37390227/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10339077/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10339077/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10339077/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
